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As compared to pediatric and older adult cancer patients, young adults are the only 
oncology group that has not demonstrated an increase in survival rates.  Low treatment 
adherence rates have been one explanation for this discrepancy, although this hypothesis 
has not been explored specifically.  Guided by the biopsychosocial model of health and 
wellness, this study compared the treatment adherence rates of 46 young adult cancer 
patients (ages 18-39 years) to 46 older adult cancer patients (ages 40 years and older).  
Adherence was measured by a dichotomized variable, as yes/no, adhering to radiation 
treatment and follow-up appointments recommended by the physician, 95% of the time.  
Additionally, gender and race were explored in relationship to adherence to radiation 
treatment and follow-up appointments.  Demographic data were first extracted from the 
Cancer Registry of a Midwestern Hospital.  Then radiation appointments and follow-up 
appointments were examined for each patient, in paper and/or computerized charts, to 
determine adherence rates.  McNemar’s test was used to compare young adults and older 
adult oncology patients’ adherence rates, and Chi-square analysis was used to explore 
gender and race in relationship to adherence.  Results indicated a lower adherence rate to 
follow-up appointments for younger adults as compared to older adults, with older adults 
adhering 3 ½ times more than younger adults.  Gender was also related to follow-up 
appointment adherence, with males adhering better than females.  This study contributes 
to positive social change by increasing the knowledge base of healthcare providers on 
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Chapter 1: Introduction to the Study 
Introduction 
Young adulthood, or what is also referred to as early adulthood, is the period of 
development spanning from the 20s to the 30s, and it is characterized by peak physical 
strength (Wood, Green-Wood, & Boyd, 2011).  During this time, individuals are working 
on achieving independence and assuming many new roles and responsibilities related to 
careers and family (Wood et al., 2011).  It is a time of transition where educational goals 
are typically achieved, intimate relationships have developed, and individuals transition 
to parenthood.  Whereas issues related to choosing a career, geographic relocations, and 
decisions about long-term commitments and childbearing are common development 
concerns (Hockenbury & Hockenbury, 2012), coping with a major health crisis, such as a 
cancer diagnosis, is not consistent with the developmental milestones of this stage.  
Although a young adult may still be influenced by parental input, their recent 
independence in the early years of young adulthood renders them responsible for their 
own decision making regarding many important issues in their lives, including those 
related to physical well-being.   
According to data collected between 1975-2000 on the incidence rates of 3,224 
invasive cancer cases per year per million of the U.S. population, for individuals aged 15-
39 years, the incidence rates are higher for males than for females in the young adult 
group.  Additionally, non-Hispanic Whites in this age range has the highest incidence  
rates, and African Americans/Blacks have the highest mortality rates for the under 40 age 
group (National Cancer Institute, 2006).  The young adult population is the only group of 
2 
 
cancer patients that has not shown improvements in survival rates over the past 2 
decades, as compared to older adults and pediatric patients (National Cancer Institute, 
2004).  These numbers seem contradictory, given young adults are in peak physical shape 
at this stage.   
The purpose of this study was to explore the relationship between age of cancer 
patients and their adherence to radiation treatments and follow-up.  More specifically, I 
measured adherence rates to radiation treatments and follow-up appointments for young 
adult cancer patients, age 18-39 years, as compared to cancer patients, age 40 years and 
older.  This study is relevant in that young adult cancer patients have not experienced the 
same increases in survival rates over the past 20 years as pediatric and older cancer 
patients (National Cancer Institute, 2004).  Although there may be other factors that 
contribute to reduced survival rates for the young adult population, treatment adherence 
was the focus of this study due to the wide variation in adherence rates among young 
adults and the minimal studies exploring adherence in the young adult cancer population. 
The social change implications of the study include an increase in the knowledge 
base on the behavioral factors that impact the lack of increased longevity for younger 
adult cancer patients, as compared to pediatric and older oncology patients.  Furthermore, 
increased longevity in younger adult cancer patients would be expected to also have a 
positive impact on future generations (i.e., the offspring of cancer survivors), in addition 
to saving dollars in health care, insurance, and promoting further scientific inquiry.   
In this chapter, I will present a background on the issue of medical adherence, the 
problem studied, the purpose of the study, and the research questions.  The 
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biopsychosocial model of wellness, which was the theoretical framework for the study, 
will also be discussed, in addition to the rationale for a quantitative design.  Subsequent 
subsections of this chapter will include assumptions and limitations of the study and 
further explanation of the significance and social change implications of measuring 
adherence in young adult cancer patients.   
Background 
Cancer is a diagnosis that can affect any person at any age.  According to the 
American Cancer Society (2012), it was estimated that there will be at least 1,638,910 
new cancer cases diagnosed in the United States alone.  Although the risk of cancer 
increases with age, according to the National Cancer Institute (2004), there are 70,000 
adolescents and young adults (ages 15-39 years of age) diagnosed with cancer each year.  
The 5-year survival rate for all cancers has increased to 67% between 2001-2007 with 
childhood cancer mortality rates decreasing by 66% over the past 40 years (American 
Cancer Society, 2012).  However, whereas mortality rates have decreased for pediatric 
cancer patients and older adult oncology patients, adolescent and young adults (ages 15-
39 years) have shown minimal improvement in survival over the past 20 years.  In fact, 
the age range of 25-35 years has shown no evidence of improvement in survival.  
Additionally, although the 5-year survival for 15-29-year olds has increased overall 11% 
between 1975 and 1997, the average annual percent change in 5-year survival for the 
following age groups were as follows:  15-20 year age group (.90%), 20-25 year age 
group (.59%), 25-30 year age group (.03%), 30-35 years age group (.-18%), and 35-40 
year age group (.23); (Bleyer, O’Leary, Barr, & Ries, 2006; National Cancer Institute, 
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2004).  The lack of increased survival for the young adult population presented an 
opportunity for further exploration of this topic.   
There have been several reasons cited for the lack of increased survival rates for 
the young adult cancer population.  Martin et al. (2007) cited health insurance status and 
delays in diagnosis as explanations for this discrepancy in survival rates between age 
groups.  Additionally, the National Cancer Institute (2004) cited several other reasons for 
the lack of increased survival rates in adolescent and young adult patients:  (a)  physician 
inconsistency in treatment and follow-up recommendations, (b) a lack of knowledge 
regarding the biological and etiologic differences in young adult cancer patients, (c) poor 
data collection on survival rates by cancer reporting agencies, (d) low participation in 
clinical trials for this age group, and (e) a lack of focus on prevention and early detection.  
Another factor that contributes to the lower survival rates for young adults is that certain 
cancers may be more aggressive in the young adult population (Bleyer, 2007).  
Furthermore, delays in treatment, coupled with delays in diagnosis, could account for the 
lack of improvements in survival rates for young adult cancer patients.  Age differences 
may affect prompt treatment decisions.  Meyer, Talbot, and Ranalli (2007) found that 
older males were more likely to make immediate treatment decisions than younger males 
when diagnosed with prostate cancer.  Similarly, older female breast cancer patients are 
also more likely to make immediate treatment decisions (Meyer, Russo, & Talbot, 1995).  
Woodhead, Lynch, and Edelstein (2011) found that younger adults were more likely to 
use data-driven strategies for decision making in a hypothetical lung cancer scenario, 
whereas older adults were more likely to use an experience-based approach to decision 
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making.  Young adults may be using different decision-making strategies than older 
adults, thereby influencing adherence to treatments, which could affect survival rates.   
Treatment adherence could also explain the lack of increased survival for the 
young adult population.  The issue of medical adherence has been studied for some time.  
However, studies on young adulthood cancer treatment nonadherence rates are few and 
have found rates ranging from 1% (Mitchell et al., 2004) to 47% (Tebbi et al., 1986).  
According to Brannon and Feist (2004), adherence has been measured in six general 
ways in the literature:  gathering information from the physician, self-report of the 
patient, collecting information from others, counting medications, examining biochemical 
substances, or a combination of the various measures.  There are advantages and 
disadvantages to these adherence measuring strategies.  For example, physician reports 
and self-reports are both subjective and have validity issues.  Patient self-report measures 
may be prone to validity issues for several reasons (e.g., the patient does not want to 
appear noncompliant, memory issues).  Medication counting can also be inaccurate (e.g., 
the patient may remove part of the medication to appear adherent).  Biochemistry, on the 
other hand, can provide a more objective way of measuring adherence.  However, not all 
treatments can be measured in this manner.  Although all approaches have their 
disadvantages, the least valid approach is physician report.  
In spite of the extensive study of medical adherence, I could not find any studies 
on radiation treatment adherence rates in young adult cancer patients as compared to 
older cancer patients.  Radiation treatment adherence is important to survival rates of 
patients because patients must receive a specific dosage of radiation within a certain time 
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frame in order to get the most benefit from the treatment.  Any missed appointments 
potentially reduce the effectiveness of the treatment.  The recommended adherence cutoff 
is typically 95% of the recommended dosage of radiation treatment, so that patients 
receive an appropriate amount of radiation in order to decrease tumor growth, improve 
prognosis, and thereby potentially increase survival (International Commission on 
Radiation Units and Measurement, 2014; Radiation Therapy Oncology Group, 2011). 
Theoretical Framework for the Study 
The biopsychosocial model of health and wellness was the theory of inquiry for 
this study.  According to the biopsychosocial approach, there is a complex interaction 
between biological, psychological, and social/cultural factors that can contribute to, or 
impede, health and wellness (Engel, 1977).  According to this model, multiple factors, 
such as genetics, decision-making skills, self-efficacy, lifestyle factors, coping skills, 
group belongingness, access to health care, and stress management can help promote or 
impede health and wellness (Engel, 1992). 
There are many biological, psychological, and social factors that could contribute 
to treatment adherence.  For example, biological factors, such as stage of disease, might 
impact the follow through of patients.  Furthermore, social factors, such as support 
system, and religious beliefs may also impact treatment adherence, whereas 
psychological factors, such as anxiety and depression, may also play a role (Brannon & 
Feist, 2004).  Young adulthood is a stage of development spanning the years of 18-39.  
Individuals at this stage of development are different biologically, financially, socially, 
emotionally, and cognitively, as compared to older adults.  Most young adults are in good 
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to excellent physical health, but this age group is also more likely to engage in unhealthy 
lifestyle behaviors (such as smoking, drinking, other drug usage), which can have long-
standing consequences (Dolinoy & Jirtle, 2008).  In the early years of young adulthood, 
individuals are beginning to live independently, are more likely to live in poverty, and are 
less likely to have access to health insurance (Park, Mulye, Adams, Brindis, & Irwin, 
2006).  The brain also continues to develop into the early 20s.  Mature thinking, 
characterized by being able to see gray areas, not just think in terms of black and white, 
gradually develops over young adulthood and middle age. Young adults are also more 
likely to blame themselves when a conflict arises (Blanchard-Fields & Norris, 1994).  
These biological, psychological, and social factors all have the potential to impact and 
interact with a young adult’s decision making in following treatment recommendations 
and on their coping skills in dealing with an illness (Mor, Allen, & Malin, 1994; Stava, 
Lopez, & Vassilopoulou-Sellen, 2006).  Therefore, measuring a behavior, such as 
treatment adherence, can have an impact on mortality, which is a biological factor.  
Hence, the biopsychosocial model of health and wellness was chosen as the framework 
for exploring adherence to radiation treatment and follow-ups to help explain the 
differences in survival rates for young adults as compared to older cancer patients.   
Problem Statement 
Young adults have been the only population to not demonstrate an increase in 
survival rates for cancer over the past 2 decades, in spite of increases in survival for both 
pediatric and older oncology patients (American Cancer Society, 2012).  Although 
several reasons have been cited as possible explanations for the low survival rates in 
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young adults, the issue of treatment adherence has not been addressed in relationship to 
oncology patients in the young adult age group, and therefore, is a gap in the literature to 
consider.  Additionally, in the studies that do exist on the young adult population, 
treatment adherence rates vary considerably from 53% (Tebbi et al., 1986) to 99% 
(Mitchell et al., 2004).  Furthermore, many scholars have used small samples.  Young 
adults are different in terms of health insurance status, financial stability, cognitive skills, 
and attitudes towards a healthy lifestyle compared to other age groups (Papalia, Duskin-
Feldman, & Martorell, 2012).  All of these factors may impact the young adult’s ability to 
adhere to medical recommendations, which subsequently could affect survival rates.  
Race and gender are also linked to survival rates and may be related to other factors, such 
as socioeconomic status in the case of race, and financial stability in the case of gender. 
Therefore, adherence rates were explored in relationship to age, and gender and race was 
also investigated in relationship to treatment adherence. 
Purpose of the Study 
The purpose of this study was to explore young adults (ages 18-39 years of age) 
adherence to cancer treatment, as compared to older cancer patients.  Failure to adhere to 
treatment and follow-up appointment recommendations may help explain the lack of 
improved longevity rates for the young adult group, which appears to be an area that is 
understudied in the literature.  The study was quantitative in nature, with the independent 
variable being age range (18-39 years vs. 40 years and older) and the dependent variables 
being adherence to radiation treatments and follow-up appointments.  Gender and race 
were also be explored in relationship to treatment adherence.  These variables were 
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explored due to the established differences in survival rates for males and females and 
Blacks as compared to other groups (National Cancer Institute, 2004). 
Research Questions and Hypotheses 
The biopsychosocial model of wellness was the foundation of the study.  In this 
study, I explored the relationship between age range of the cancer patient and adherence 
to cancer radiation treatment recommendations and physician recommended follow-up  
appointments.  The method for measuring adherence was determining whether patients 
adhered at least 95% of the time to the radiation treatment and follow-up appointments 
recommended by the physician.  Several scholars have used similar approaches to 
measuring adherence (Cooper, Schultz, Simpkins, and Lafata, 2007; Stensvold et al., 
2011; Weggelaar, Aben, Warle, Strobbe, & van Spronsen, 2011; Winkeljohn, 2010).  
However, researchers have not compared young adult cancer patients to older adult 
cancer patients in relationship to adherence to radiation and follow-up appointments.  
Measuring adherence rates of young adult cancer patients is important to increase the 
knowledge base of survival rates for young adults with cancer.  Additionally, a better 
understanding of treatment adherence rates could lead to further studies on the reasons 
for the discrepancy and ways to improve adherence rates.   
The following are the research questions and hypotheses for the study: 
1.  Is there a significant difference in radiation treatment adherence for young 
adult patients as compared to older adult oncology patients?   
H01:  Young adult oncology patients do not adhere to radiation treatment less than 
older adult oncology patients. 
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H11:  Young adult oncology patients do adhere to radiation treatment less than 
older adult oncology patients.   
2. Is there a difference between young adult cancer patients and older adult 
cancer patients, in terms of adherence to follow-up appointment 
recommendations? 
H02:  Young adult oncology patients do not adhere to follow-up appointments less 
than older adult oncology patients. 
H12:  Young adult oncology patients do adhere to follow-up appointments less 
than older adult oncology patients. 
3. Does gender impact adherence to radiation treatment? 
H03:  There is no association between gender and radiation treatment adherence.   
H13:  There is an association between gender and radiation treatment adherence. 
4. Does gender impact adherence to follow-up appointments?   
H04:  There is no association between gender and adherence to follow-up 
appointments.  
H14:  There is an association between gender and adherence to follow-up 
appointments. 
5. Does race impact adherence rates to radiation treatment appointments?   
H05:  There is no association between race and radiation treatment adherence.   
H15:  There is an association between race and radiation treatment adherence.   
6. Does race impact adherence to follow-up appointments? 
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H06:  There is no association between race and adherence to follow-up 
appointments.   
H16:  There is an association between race and adherence to follow-up 
appointments. 
The independent variable was age group (i.e., 18-39 years vs. 40 years and older), 
and the dependent variables were adherence to radiation treatments and follow-up 
appointments (i.e., operationally defined as either yes or no, the patient completed 95% 
of the radiation treatments and follow-up appointments on time as recommended by the 
physician).  Race and gender were also explored in relationship to adherence to radiation 
and follow-up appointments. 
Nature of the Study  
The research was quantitative and involved the secondary analysis of previously 
gathered data in order to measure the adherence of cancer patients.  The data gathered 
included demographic information (i.e., age, gender, race) and treatment-related 
information (i.e., number of radiation treatments and follow-up appointments 
recommended by the physician, and number completed as recommended in order to 
determine if patient adhered at least 95% of the time). 
The data were extracted from the Cancer Registry database of a Midwestern 
Hospital, with the assistance of the Cancer Registrar.  The Cancer Registry gathers data 
from past and current oncology patients, both inpatient and outpatient, and the 
information is submitted to a national data base that cancer centers in the United States 
report to on a regular basis.  Additionally, information was extracted from the patient 
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charts, which lists radiation treatment and follow-up appointment recommendations and 
whether or not and when the patient followed through with the appointment and/or 
treatment recommendations.   
Two groups of patients were requested from the registry data base.  One group 
was between the ages of 18-39 and the other were 40 years of age and older.  Patients 
were from a variety of ethnic backgrounds, with the expectancy that there would be a 
larger than national average Hispanic population due to the location of the hospital.   
The cancer registrar selected the 46 available cases from the young adult age 
group and then matched 46 older adult oncology patients on race, gender, and diagnosis.  
Because the software does not have the capability to randomly select a single matched 
case, when there were multiple options in the older adult group, one case was randomly 
selected from those available.  Forty-six cases were chosen due to the limited number of 
young adult cases available.  This number still represented over sampling to account for 
missed data which could have required cases be eliminated from the study.  Patient charts 
were then reviewed to determine how many radiation treatments were recommended by 
the physician and how many were completed as recommended by the physician.  
Additionally, data regarding the recommended follow-up dates and the number 
completed on time by the patient, as compared to how many were cancelled or postponed 
by the patient was collected. 
The age of 39 years was chosen as a cut-off age because major organizations, 
such as the National Cancer Institute, use this as the cut-off for the classification of young 
adult cancer patients (National Cancer Institute, 2004).  The following are a description 
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of the main variables which were explored: (a) treatment recommendations:  number of 
radiation treatment recommended vs. number of radiation treatments completed.  
Radiation treatment appointments were selected as the variable because of the set number 
of consecutive appointments each patient is prescribed at the onset of treatment and the 
clear documentation of attendance in the patient files.  Chemotherapy adherence, on the 
other hand, would be much more difficult to monitor due to the length of time the patient 
may receive treatment and the increased likelihood of other variables that may contribute 
to postponed treatments (e.g., side effects, low blood counts, changes in chemotherapy 
agents).  Adherence to radiation treatment was considered as yes if the patient completed 
95% of the appointments as recommended; (b) frequency of follow-ups:  number of 
follow-up appointments recommended by physician and number of radiation treatment 
follow-up appointments completed and number missed or postponed by patient.  
Adherence was considered as yes if the patient completed 95% of their follow-up 
appointments as recommended; (c) gender:  categorized as either male or female; (d) 
race:  categorized as minority or White/Non-Hispanic 
Only those patients who had started radiation treatment, not those who had 
refused treatment, were included in the study.  This is because those who refused 
treatment would have qualified as 100% nonadherent and thus would be outliers.  In the 
event that there were participants who were selected for the sample and refused to follow 




Scope and Delimitations 
In this study, I explored treatment adherence rates of young adult oncology 
patients as an explanation for the lack of increase in survival rates for this population, as 
compared to pediatric and older adult oncology patients.  Adherence was chosen as the 
focus of the study after I observed what appeared to be a significant difference in the 
young adult population’s compliance with radiation treatment and follow-up 
appointments.  However, there were delimitations in the study.  I only looked at 
adherence to radiation treatment as an explanation for the lack of increased survival in the 
young adult population, and I did not include adherence to other types of treatment (e.g., 
chemotherapy, surgery). 
The biopsychosocial model was chosen as the foundation of the study because it 
is a more inclusive model for exploring health-related issues, examining biological, 
psychological, and social factors in explaining disease outcome.  For example, the model 
could predict whether behavioral factors (e.g., nonadherent behavior) affected biological 
factors (such as cancer outcome or death).  The method and dataset were chosen because 
a quantitative study is a more accurate reflection of adherence rates as opposed to a 
qualitative study.  Additionally, by using de-identified existing data, I removed subject 
burden and the potential for revealing of identity. 
Assumptions and Limitations 
This study was based on the assumption that the demographic data and treatment 
attendance were entered correctly into the patient’s electronic and paper chart files.  
Given that humans are not infallible, there is always the possibility of errors in the data 
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collection, and because some of the data were not directly collected by me, there was no 
way of knowing this.  Additionally, the data were secondary in nature and were not 
gathered for the purpose of this study; therefore, it may not be collected in a way that is 
best for the purposes of this study.  In addition, missing data was also a potential issue.   
One limitation of this particular study relates to generalizability.  This study 
cannot be generalized to the U.S. population as a whole, as the community sample is 
likely not representative of the United States in terms of ethnicity, socioeconomic status, 
or educational level.  Another limitation of this study was that I only addressed radiation 
treatment adherence, as opposed to other treatments, such as chemotherapy and surgery.  
Radiation treatments were chosen as a measure of adherence, due to the ability to 
quantify the attendance and completion of treatment sessions more easily, than 
chemotherapy appointments.  This is due to the nature of the documentation in the charts 
(i.e., they are recorded more as an attendance record) and because radiation treatments 
are typically done consecutively, 5 days a week, as opposed to chemotherapy treatments, 
which may have weeks between treatments, and the potential for postponing due to other 
issues (e.g., low blood counts, side effects, changes in chemotherapy agents). 
Another limitation of the study was that adherence was only measured at one 
hospital.  Therefore, it was unclear as to whether or not individuals who dropped out of 
treatment, and were considered nonadherent, possibly continued treatment at another 
facility.  However, the number of participants for which this latter issue might apply was 




Whereas health insurance status, the lack of immediacy in making treatment 
decisions, and other factors have been explored as explanations for the lack of increased 
survival for younger adults, consistency and follow through in treatment does not appear 
to have been explored in relationship to this issue with younger cancer patients.  As an 
oncology counselor/art therapist for the past 6 years, I have noticed that the younger 
patients do not follow through with treatment recommendations and follow-ups as 
consistently as the older patients.  Therefore, I was interested in exploring the differences 
between younger adult cancer patients (ages 18-39) and older adult cancer patients (ages 
40 and older) and their adherence to treatment recommendations and follow-up 
appointments to help determine if what I was seeing anecdotally was supported by 
scientific inquiry.  Identification of a difference could have an impact on future studies, in 
that it would make cancer treatment adherence a focus of future studies in terms of 
exploring why adherence rates are low and identifying ways to increase treatment 
adherence.    
The results of this study could provide additional knowledge on the behavioral 
factors that impact the lack of increased longevity for younger adult cancer patients, as 
compared to pediatric and older oncology patients.  Furthermore, increased longevity in 
younger adult cancer patients would be expected to also have a positive impact on future 
generations (i.e., longer survival rates for young adult cancer patients could have positive 
benefits for the offspring of the patient, in that children are not having to deal with the 
loss of a parent before they are developmentally ready to cope with such a loss).  
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Additionally, a better understanding of adherence rates for young adults has implications 
for future scientific inquiry which could focus on understanding the reasons for low 
adherence rates and ways to increase adherence.  This, in turn, has practical applications 
of improving the adherence rates of this population, thereby improving health by 
reducing the chance of disease reoccurrences or metastatic disease, which could lead to 
disabling effects, and saving money for not only insurance vendors, but also patients and 
their families. 
Summary 
Young adulthood is a stage of development typically characterized by many 
changes, both occupationally and relationally.  It is also a stage of peak physical strength.  
However, it is not a stage where individuals typically prepare themselves to deal with a 
major health crisis, such as a cancer diagnosis.  There have been several explanations as 
to why young adults have been the only age group over the past 2 decades that have not 
shown an improvement in cancer survival rates (National Cancer Institute, 2004).  
Insurance status, poor data collection by agencies reporting cancer statistics, inconsistent 
treatment and follow-up recommendations, limited knowledge regarding the biological 
and etiologic differences in young adult cancer patients, poor clinical trial participation, 
and a lack of focus on prevention and early detection are just some of the areas that have 
been cited as reasons for this discrepancy (National Cancer Institute, 2004).   
In this study, however, I focused on significantly lower adherence rates to 
radiation treatment and follow-up appointments as a potential explanation for the limited 
change in survival rates for young adult cancer patients over the past 20 years.  I used the 
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biopsychosocial model of health and wellness as a foundation for comparing the radiation 
treatment and follow-up appointment adherence rates of young adult cancer patients 
(ages 18-39 years) to older cancer patients’ (ages 40 and above) adherence rates.  
Quantitative data were gathered from the Cancer Registry database and patient charts of a 
Midwestern community hospital cancer care center.   The study was retrospective in 
nature.  The demographic variables of race and gender were also explored in relationship 
to the adherence rates. 
Chapter 2 provides a synopsis of the most recent literature related the 
developmental stage of young adulthood, the young adult cancer research, treatment 
adherence, in addition to gender and race in relationship to survival rates.  Additionally, 
studies related to coping styles and decision-making strategies in relationship to age and 
the diagnosis of cancer are reviewed.  Furthermore, the biopsychosocial model of health 
and wellness is discussed in more detail. 
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Chapter 2: Literature Review 
Introduction 
Cancer, which is a leading cause of death, affects individuals of all ages.  In the 
United States alone, it was estimated that there will be at least 1,638,910 new cancer 
cases diagnosed each year (American Cancer Society, 2012).  Of these newly diagnosed 
cases, 70,000 (approximately 4%) will be adolescents and young adults between the ages 
15-39 years (National Cancer Institute, 2004).  Survival rates are of great interest when 
discussing cancer and are continually being reported for the cancer population.  Whereas 
the 5-year survival rate for all cancers has increased from 49% in 1975-1977 to 67% 
(2001-2007), and childhood cancer mortality rates have decreased by 66% over the past 
40 years, adolescent and young adults (ages 15-39 years) have shown minimal 
improvement in survival over the past 20 years (American Cancer Society, 2012).  The 
age range of 25-35 years has shown no evidence of improvement in survival (National 
Cancer Institute, 2004).  Additionally, a study conducted in England showed limited 
improvements in survival rates for some diagnostic groups in the 13-24 year age cancer 
population (Geraci et al., 2009).   However, this increase appears to vary according to 
region and did not appear to be related to socioeconomic status.  Furthermore, the overall 
5-year survival rate for the young adult cancer population in England during the time of 
the study was 55%, which was considerably less than the survival rate of pediatric 
patients, which was 83% (Geraci, et al., 2009).  Survival rates for young adults are not 
only a concern in North America, but also in England.   
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Scholars who examine factors related to survival are plentiful.  According to 
Miller, To, Baines, and Wall (2002), the success in improving survival rates for some age 
groups, has been credited to improvements in screening, particularly mammography, 
adjuvant chemotherapy and hormonal therapy advancements, in addition to treatment 
guidelines for early stage cancers.  Improved diagnostic and treatment guidelines, 
particularly, at the early stages of diagnosis, could potentially improve prognosis and 
survival rates. 
Although several variables have been explored to explain the lack of 
improvement in survival rates for the young adult age range, there appears to be a gap in 
the literature in regards to exploring adherence rates for different young adult age ranges.  
The purpose of this chapter is to provide a review of the most recent literature related to 
cancer survival and to demonstrate a gap in the literature as it relates to comparing young 
adulthood age groups and cancer treatment adherence.  Initially, survival as it relates to 
gender and race will be discussed, followed by a description of the biopsychosocial 
model of health and wellness as compared to the biomedical model.  Subsequently, there 
will be a discussion of the developmental milestones of young adulthood, followed by a 
literature review of young adults with cancer as it relates to the lack of increased survival 
rates in young adult cancer patients.  Additionally, a discussion of the most common 
cancer diagnoses in the young adult population, in addition to risk factors and cancer 
staging, will be discussed.  Treatment adherence as it relates to the biopsychosocial 
model of health and wellness will be discussed, followed by a review of the treatment 
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adherence literature.  In the final section, strategies for increasing treatment adherence 
will be discussed.  
Literature Search Strategy 
A literature search was conducted electronically in the psychology and medical 
databases such as PsycARTICLES, PsycInfo, MEDLINE, and CINAHL through the 
Walden University and Elgin Community College EbscoHost library databases.  Search 
terms included the following:  treatment adherence and cancer, cancer treatment 
adherence and young adults, treatment adherence and young adults, adherence and 
young adults, young adulthood and treatment adherence, young adults and cancer, 
biological factors and treatment adherence, psychological factors and treatment 
adherence, sociological factors and treatment adherence, survival rates in young 
adulthood, and the biomedical and biopsychosocial models of health and wellness.  
Additionally, other sources were reviewed, such as data from the National Cancer 
Institute, the American Cancer Society, and the National Comprehensive Cancer 
Network.  Google Scholar and PubMed databases were also accessed for articles.  
Additionally, articles of relevance that were referenced in the primary sources were also 
accessed and reviewed.  
Theoretical Foundation/Conceptual Framework 
According to the biopsychosocial model (Engel, 1992), health and wellness is not 
only related to biological factors, but also can be attributed to psychological and social 
factors.  Psychological factors include such personality traits as locus of control, coping 
skills, defense mechanisms, self-efficacy, decision making, and adherence to medical 
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advice, while sociological factors include such variables as socioeconomic status, 
ethnicity, and group belongingness (Engel, 1992).  According to the theory, these 
psychological and sociological factors interact with biological factors (e.g., genetics, age, 
vulnerability to stress, nutrition, exercise, brain maturation) to produce health or disease 
(Brannon & Feist, 2004; Green & Shellenberger, 1990). 
Engel (1992) is the person most closely associated with the biopsychosocial 
model.  The biopsychosocial model is an inclusive model for explaining disease.  
Whereas biological factors may account for the onset of the disease, psychological and 
social factors impact when the person actually begins to feel ill, when he or she accepts 
him or herself as being ill, and when he or she enters the health care system.  The patient 
and the social context in which he or she lives, and the role of the physician and the entire 
health care system, should be taken into consideration when treating illness and disease 
(Engel, 1997).  Additionally, according to Engel (2005), any information communicated, 
either verbally or nonverbally by the patient to the physician, qualifies as psychosocial.  
Furthermore, Engel (2005) believed that a successful biopsychosocial approach requires 
the physician to understand how the symptoms are integrated into the content of the 
patient’s life.    
The biopsychosocial model’s roots are the biomedical model, a model that had 
dominated research, education, and modern medicine for over a century.  The biomedical 
model is a scientific model with molecular biology roots and focuses on a more uni-linear 
concept of etiology (Engel, 1992).  Proponents of this view see disease as being solely 
due to biological variables and believe that the disease must be, therefore, treated 
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biologically (Engel, 1992).  The model gives autonomous power to the physician as the 
primary care provider.  The biomedical model is also reductionistic (i.e., there is a single 
primary explanation for disease) and dualistic in nature (i.e., the mind and body are 
separates entities).  The biomedical model is also exclusionistic in that it implies that any 
issue that cannot be explained in terms of biochemistry should be excluded from the 
category of disease (Engel, 1992).  However, the exclusion of psychosocial factors in 
explaining disease not only distorts what qualifies as disease, but also interferes with 
patient care (Engel, 1992).  Therefore, a biopsychosocial model is a more inclusive model 
for examining illness and disease.   
Regardless of a person’s developmental stage in the lifespan, there are biological, 
psychological, and sociological factors that may impede or improve health and wellness.  
The stage of young adulthood, which will be the primary focus of this chapter, will be 
discussed next.   
Young Adulthood 
Young adulthood is a stage characterized by many changes in career, work, 
relationships, and childbearing.  Young adults are transitioning into careers and the 
workforce, making decisions about a long-term partnership with a significant other, in 
addition to starting families.  Throughout the entire stage of young adulthood, which 
spans 18-39 years of age, a person can have more than one career, give birth to children, 
and begin the process of helping their own children establish their own identity and 
choose a career.  However, some young adults are waiting longer to leave their family of 
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origin and start their own careers and families (Benson, Kirkpatrick Johnson, & Elder, 
2011).  Typically, it is a stage characterized by growth, not coping with major illnesses. 
Young adults present with their own set of physiological, psychological, and 
sociological characteristics.  In addition to being in a stage of transition, early young 
adulthood, along with adolescence, has been described as a stage of risk taking behavior.  
Risky behaviors during these stages can lead to social, economic, and public health issues 
(Romer, 2003).  Adolescents and young adults are responsible for a larger proportion of 
crime, more deadly vehicular crashes, and more newly diagnosed cases of HIV-Aids 
(Romer, 2003).  Furthermore, this population is more likely to engage in unhealthy 
habits, such as smoking cigarettes, drinking alcohol, using drugs, and having a poor diet, 
which have an impact on longevity in later adulthood (Romer, 2003).  Reyna et al. (2011) 
found that the 18-21-year-old age group is especially prone to sensation seeking 
behaviors.  However, this is due to feelings of being invulnerable or being unconcerned 
about potential risks (Steinberg, 2007), but due to poor impulse control and emotional 
regulation and the inability to resist peer pressure and delay gratification; these 
characteristics appear to be tied to neurobiological maturation, particularly the limbic 
system and prefrontal cortex (Steinberg, 2007).  These two areas gradually mature over 
the course of adolescence and early young adulthood (Steinberg, 2007).  Additionally, a 
reduction in parental monitoring and increased peer contact also may play a role in early 
young adulthood health risk behaviors (Fisher & Feldman, 1998).   Therefore, young 
adults may find themselves engaging in unhealthy behaviors which may contribute to, or 
exacerbate, a major illness or injury.        
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Young Adults with Cancer 
Although the main causal factor for death in young adults is accidental, cancer is 
the most common natural cause of death among this population (Albritton & Bleyer, 
2003).  Therefore, it is important to have an understanding of young adults with cancer.  
Haase and Phillips (2004) described adolescents/young adults with cancer as an invisible 
population for three reasons: (a) adolescents/young adults are not distinguished from 
children and older adults in the literature, (b) this age group rarely receives care in an 
appropriate setting (i.e., they are treated in pediatric or adult oncology treatment centers), 
and (c) there is a lack of understanding regarding adolescents/young adults lack of 
commitment to treatment.  Additionally, although developmental theories are often 
applied to understanding cancer, the discussion does not include the possibility of a 
serious illness during the developmental stage of young adulthood (Sunmi, 2001), which 
could potentially contribute to late diagnosis. 
The cancer spectrum is much different for the adolescent/young adult population 
as compared to the pediatric and middle aged/older adult population.  The most 
commonly diagnosed malignancies in adolescent and young adult cancer patients, aged 
15-39 years of age, are lymphomas, genitourinary and gastrointestinal carcinomas, 
leukemias, and melanomas (Holland, 2009).  Whereas embryonal tumors are more 
common in children younger than 15 year of age, adults, 40 years of age and older, are 
primarily diagnosed with lung, prostate, breast, and colorectal cancers (Bleyer et al., 
2008).  Some of the cancers more likely diagnosed in young adulthood (e.g., melanomas) 
tend to be more aggressive than other cancers (National Cancer Institute, 2004).  The 
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primary cancers for females, ages 15-39 years of age, are breast (20.4%) and thyroid 
carcinomas (14.6%), melanoma (9.5%), carcinomas of the cervix and uterus (9.1%), 
Hodgkins lymphoma (3.7%), and carcinoma of the colon and rectum (3.4%); (National 
Cancer Institute, 2004).  For males in this age group, the primary cancers are gonadal 
germ cell tumors (10.1%), melanoma (5.5%), non-Hodgkin’s lymphoma (4.7%), 
carcinoma of the colon and rectum (3.6%), and thyroid carcinoma (2.9%) as reported by 
the National Cancer Institute (2010).  According to the National Comprehensive Cancer 
Network (NCCN) colon cancer for this population tends to be at the more advanced stage 
at time of diagnosis, and there is an increased risk for additional malignant tumors 
(2012).  The cancer diagnosis, therefore, may impact survival rates for this population.  
Additionally, there is a need for early detection with more aggressive forms of cancer. 
Risk Factors for Cancer in Young Adults 
There appears is little evidence of a single common genetic component for 
developing cancer prior to age 30 (NCCN, 2012), and there are no identified risk factors 
for all cancers diagnosed for the 15-29-year-old age range (Bleyer, Viny, & Barr, 2006).  
However, young adults are at increased risk of developing a secondary malignancy due to 
chemotherapy and radiation exposure if they have a childhood cancer history.  
Additionally, maternal exposure to diethylstilbestrol (DES), a drug given to pregnant 
women in the past, increases the chance of vaginal and cervical cancers in offspring 
(Bleyer et al., 2006).  Other risk factors include exposure to ultraviolet light and 
contracting the human papillomavirus (HPV), the latter which is a risk factor for cervical 
Carcinoma (NCCN, 2012).  The Epstein-Barr infection and HIV are also risk factors for 
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Hodgkin’s lymphoma and Kaposi Sarcoma and non-Hodgkin’s lymphoma (NCCN, 
2012).   
Breast cancer is also more likely to occur in young adults when they possess the 
BRCA-1, BRCA2, and TP53 genetic mutation (National Cancer Institute, 2004) or they 
have received radiation for Hodgkin’s lymphoma.  Inflammatory bowel disease and 
radiation exposure are also risk factors for colorectal cancers in this age group (National 
Cancer Institute, 2004).  Young adults may also possess a genetic mutation, referred to as 
Lynch syndrome, which is associated with colon cancer (Alman, Pajerski, Diaz-Cano, 
Corby, & Wolfe, 1997).  There are also genetic mutations associated with the 
development of sarcomas in the young adult population (NCCN, 2012).  Although, there 
is no single explanation for the development of cancer in the young adult population, 
there are some risk factors associated with developing specific cancers and secondary 
malignant tumors.   
Cancer Staging 
The stage at which a person is diagnosed can also impact survival rates.  Cancer 
staging is designed to describe the severity of the disease.  Staging also assists in 
treatment planning and determining prognosis.  Staging is determined by physical 
examination; pathology and laboratory reports; imaging techniques such as computerized 
axial tomography, magnetic resonance imaging, and positron emission tomography; in 
addition to surgical biopsies (National Cancer Institute, 2010).  Staging involves 
identifying the site, size, and number of the primary tumor(s), whether or not there is 
lymph node involvement, the cell type and the degree to which it resembles normal tissue 
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(i.e., grade), and whether or not the disease is localized or systemic (i.e., metastasized; 
National Cancer Institute, 2010).  The current staging process is the TNM system 
(National Cancer Institute, 2010).  T is indicative of the tumor size, N indicates whether 
or not the cancer has spread to the nearby lymph nodes, and M refers to whether distant 
metastasize has occurred (National Cancer Institute, 2010).  Tumors are described as 
being in stage 0-IV, with IV being the most serious.  
Based upon the staging of the disease, physicians use statistical data in order to 
provide a prognosis for the patient.  A prognosis is an estimation of the outcome of the 
disease for the patient, with and without treatment (National Cancer Institute, 2010).  
Many factors can impact the prognosis, such as type and location of the tumor, size of the 
tumor, how quickly the tumor is growing, age, presence or absence of comorbid disease, 
the response to treatment, and the patient’s adherence to the treatment regimen (National 
Cancer Institute, 2010).  Cancer diagnosis and staging both influence treatment regimens, 
which will be discussed next.   
Treatment Regimens 
Adolescent/young adult patients are more tolerant of intense therapies due to their 
decreased likelihood of having co morbidities, as compared to older patients.  Although 
dose intensive treatment is associated with more positive outcomes, treatment effects 
must be closely monitored to avoid permanent organ damage (NCCN, 2012).  The 
primary treatment options for the young adult cancer population are surgery, radiation 
therapy, chemotherapy, and stem cell transplantation (NCCN, 2012).  Surgery is more 
tolerable for the young adult population, as opposed to pediatric and adolescent patients, 
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because their bodies are fully developed.  Additionally, pediatric patients are more 
sensitive to anesthesia, as are older patients.  Older patients also have more co 
morbidities than young adults, making them less than ideal candidates for surgery 
(NCCN, 2012).   
Radiation, which is another common treatment, has many side effects, including 
increased risk of secondary malignancies; lung, heart, and thyroid problems; other 
chronic health conditions; and growth dysfunction (Armstrong, Stovall, & Robinson, 
2010).  Additionally, radiation therapy to the testes and ovaries increases the risk of 
infertility, and chest radiation increases the risk of later developing breast cancer (Levine, 
Canada, & Stern, 2010).  Cranial radiation therapy (i.e., radiation to the head region) also 
has many associated effects, including cognitive impairment which contributes to lower 
employment rates, relationship issues, and the decreased likelihood of living 
independently (Janson et al., 2009).  .   
Chemotherapy is a common treatment method for all age ranges, but it can lead to 
specific issues for the young adult population.  Young adults are in the childbearing 
stage, so concerns about fertility issues in both males and females is an issue for this age 
range (Levine et al., 2010)  Cardiac, central nervous system dysfunction, hearing loss 
(Schell et al., 1989), and renal dysfunction (Hijiya, Ness, Ribeiro, & Hudson, 2009) are 
also potential side effects of chemotherapy.  Additionally, pain, fatigue, nausea, 
vomiting, hair loss, infection, oral inflammation, and inhibition of bone marrow function 
are common side effects (NCCN, 2012).  Unless contraindicated, the dose should be as 
intense as possible for this population.  However, dose reductions are implemented when 
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necessary to avoid permanent organ damage (NCCN, 2012).  Conditioned nausea and 
vomiting are also common chemotherapy side effects, and they occur more frequently in 
patients younger than 50 year of age (Roscoe, Morrow, Aapro, Molassiotis, & Olver, 
2011). 
Hematopoietic stem cell transplants, also known as a bone marrow transplant, 
have been found to be a curative option for young adults with leukemias and lymphomas. 
Unfortunately, as with any transplant, there is the potential for many serious side effects.  
Organ rejection and immune system suppression are two major concerns following 
transplant.  Additionally, posttransplant complications, infections, and other organ 
dysfunction are also concerns (Oeffinger et al., 2004).  
Although there are several treatment options available for young adults with 
cancer, they are not without their side effects and complications.  It is not surprising that 
many individuals, both young and old, find the treatment regimen difficult to adhere too. 
Psychosocial Concerns for Young Adults with Cancer 
There are many psychosocial issues to consider for adolescent and young adult 
cancer patients, including their living situation (e.g., are they living with their parents, 
alone, or with a partner), their involvement in work and/or school, and whether these 
areas of life will be disrupted.  Additionally, concerns regarding alcohol/drug and tobacco 
usage, in addition to sexual behaviors, diet, exercise, and spirituality are all areas of 
consideration, given young adults are more likely to engage in unhealthy behaviors, as 
compared to older adults (Romer, 2003).  Other areas to evaluate include family and 
partner interactions/relationships, peer relationships, social and athletic activities, 
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concerns about fertility, and the young adult’s ability to communicate with their health 
care providers.  Insurance and finances can also be issues of concern, in addition to child 
care, transportation, and interest in alternative therapies (NCCN, 2012).  An adolescent 
cancer patient may also be worried about cancer reoccurrences, body image, healthcare 
and finances, and may delay developmental tasks such as marriage or starting a career 
(Zeltzer, 1993).  According to Zebrack, Mathews-Bradshaw, and Siegel (2010), all of 
these are issues which need to be addressed when treating the young adult population.  
Yet, unfortunately, many adult treatment centers neglect to provide services to address 
these psychosocial issues. 
Other areas of concern may be more emotional in nature.  For example, Sunmi 
(2001) conducted a narrative study with a young adult cancer patient and found three 
recurring themes in her study:  (a) lack of understanding from her peers and a need for 
feedback and acknowledgement regarding her disease, (b) concerns about if and how her 
cancer illness could be integrated into her identity, and (c) feelings of isolation from her 
peers due to her newfound maturity as a result of her diagnosis, that resulted in alienation 
from her less mature peers.  Although the cancer survivor in the study felt oppressed and 
isolated, she also felt that her diagnosis changed her values from being self-centered and 
materialistic, to a more socially conscious individual.  Although this study only included 
one young adult cancer patient, her remarks could lead to insight into the mind of a 
young adult cancer patient. 
A cancer diagnosis also increases the likelihood of developing other physical 
problems.  Young adults with cancer are more likely to experience cardiovascular and 
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other physical problems, compared to the general population (Chen, Colan, Diller, & 
Force, 2011) due to the effects of treatments.  Therefore, it is imperative that adolescents 
and young adults with cancer lead a healthy lifestyle to help reduce the chance of future 
problems.  Rabin (2011) explored the literature related to three health focused behaviors 
(i.e., exercise, smoking cigarettes, and alcohol and drug usage), and found that young 
adult cancer survivors are less likely to engage in physical activity, as compared to their 
healthy peers.  However, they were also less likely to smoke cigarettes, use alcohol, or 
illicit drugs.   
Factors Influencing Cancer Survival in Young Adulthood   
Cancer survival may be presented in one of four ways:  (a) cancer-specific 
survival, (b) relative survival, (c) overall survival, and (d) disease-free survival.  Cancer-
specific survival pertains to the statistical percentages of individuals who have not died 
from a specific type and stage of cancer.  Survival may be presented in terms of 1 year, 2 
years, 5 years, etc.  However, this method is prone to inaccuracies because it is based on 
what is identified as the cause of death in medical records, which may have errors.  For 
this reason, relative survival rates may be presented.  Relative survival rates compare 
survival of patients with a particular disease and stage of disease to the general 
population who are of the same age, race, and gender, but have not been diagnosed with 
cancer.  Overall survival, on the other hand, is percentage of individuals that have not 
expired during a specific time period following diagnosis, whereas disease-free survival 
is the percentage of individuals who are cancer-free following treatment for a specific 
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time period.  Cancer statistic reporting agencies, often present survival rates in terms of 
5-year survival as compared to the general population (National Cancer Institute, 2010).   
The National Cancer Institute (2004) has cited several reasons for the lack of 
increased survival rates in adolescent and young adult patients:  (a) physician 
inconsistency in treatment and follow-up recommendations, (b) a lack of knowledge 
regarding the biological and etiologic differences in young adult cancer patients, (c) poor 
data collection on survival rates by cancer reporting agencies, (d) low participation in 
clinical trials for this age group, and (e) lack of focus on prevention and early detection.  
According to Bleyer, Budd and Motello (2006), whereas approximately 10% of 
15-19 year old cancer patients participate in clinical trials, only 1-2% of the 20-39 year 
old age group does so.  Additionally, inconsistencies in treatment and presentation can 
also influence survival. McMillan and McArdle (2009) found that younger patients (less 
than 45 years) were more likely to present in an emergent state, have advanced disease 
and die of their cancer as compared to three groups of older patients, up to age 74 years.  
However, when controlling for state of presentation and disease stage, there was no 
longer a significant relationship between young age, and poorer survival outcome, which 
suggests that later diagnosis plays a major role in survival rates.      
Martin et al. (2007) also cited health insurance status and delays in diagnosis, as 
an explanation for this discrepancy between survival rates in young adulthood, as 
compared to older adults and pediatric patients.  Additionally, Meyer et al. (2007) found 
that younger adults are more likely to delay decisions about cancer treatment than older 
adults.  Older adults have more knowledge about treatments and cancer, and make more 
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immediate treatment decisions.  Similarly, older female breast cancer patients are also 
more likely to make immediate treatment decisions according to Meyer et al. (1995). 
Delays in treatment, especially coupled with delays in diagnosis, could account for the 
lack of improvements in survival rates for young adult cancer patients (Meyer et al., 
2007; Meyer et al., 1995).   
Furthermore, decision-making strategies of young adults may also impact their 
follow through with treatment, and this could affect survival rates.  Woodhead et al. 
(2011) conducted two studies comparing younger adults and older adults decision making 
strategies in a hypothetical lung cancer scenario. Results of these two studies indicated 
that younger adults were more likely to use data-driven strategies (i.e., information 
regarding survival and mortality data) for making decisions about treatment choices, as 
opposed to experience-driven decisions (e.g., making a decision based on what family or 
friends experienced when diagnosed).  That is, young adults were more likely to make 
decisions based on concrete outcomes.   
Although social support has also been tied to survival rates, social support has not 
been directly researched in relationship to survival.  However, one might be able to 
speculate that social support, which encourages treatment adherence, might lead to better 
compliance, and subsequently improve survival rates (Magai, Consedine, Neugut, & 
Hershman, 2007).   
Survival as it Relates to Gender and Race 
There are also differences in survival related to gender and race. According to the 
National Cancer Institute (2004), the mortality rates are higher for males, younger than 
35 
 
30 years of age, and older than 45 years of age.  On the other hand, more females die of 
cancer between the ages of 30 to 44 years.  Between 1975 and 2000, data shows that 
more males have died from cancer between the ages of 10 through 45 years of age, when 
comparing incidence rates.  This suggests that cancers in adolescent and young adult 
males were more lethal than for females, or that treatment was not as effective.   
Additionally, survival rates for African Americans are lower, in all age groups 
older than 15 years, and for all cancers, as compared to White non-Hispanics, Hispanics, 
Native Americans, and American Indians (National Cancer Institute, 2004).  
Additionally, although White non-Hispanics had the best survival rates, and African 
Americans had the worst survival, both of these groups experienced the least 
improvement in survival rates, over time, compared to other ethnic groups, with African 
Americans also having the least improvement, particularly for individuals between the 
ages of 15 and 24 years. 
In summary, cancer survival, which can be measured in multiple ways, is 
influenced by many factors (e.g., clinical trial participation, stage of disease at diagnosis, 
delays in treatment, age, and gender).  Treatment adherence is another factor, which may 
impact survival.  This will be discussed in the upcoming section. 
Adherence 
Treatment adherence is another factor that has been explored in young adult 
cancer patients.  Although there have been studies exploring adherence in 
adolescents/young adults, only a few articles were found that explored the relationship 
between adolescents/young adulthood and cancer treatment adherence.  Furthermore, 
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articles which did focus on young adulthood, often included only up to the age of 23 
years, and excluded the 23-39 year age group.  Given the unique psychological, 
biological, and sociological features of young adults, poor treatment adherence could also 
be an explanation for the difference in survival rates.  Following is a definition of 
adherence, a discussion on the ways in which it has been measured, in addition to a 
description of several studies which have explored adherence, and then some suggestions 
on how to improve adherence.       
Treatment adherence, which is also known as treatment compliance in the medical 
literature, is one psychological factor in the biopsychosocial model that could affect 
health.  Treatment adherence can be defined as the patient’s cooperative behaviors in 
response to physician orders (Brannon & Feist, 2004).  It can be operationally defined as 
taking medications as directed (Winkeljohn, 2010), following the steps of a stop smoking 
program, or completing treatments, such as chemotherapy on schedule, as directed by the 
physician (Weggelaar et al., 2011).  According to Kondryn, Edmondson, Hill, and Eden 
(2009), adherence should not only be described in terms of behavior, but also in 
relationship to attitude (i.e., behavioral adherence could be operationally defined as 
nonadherence to medical advice, whereas attitudinal adherence could be described as the 
willingness and intention of the patient to complete treatment and/or their thoughts about 
treatment).  Treatment adherence has been found to reduce poor treatment outcomes by 
26% (DiMatteo, Giordani, Lepper, & Croghan, 2002).   
The World Health Organization (2003) estimated that treatment adherence is 50% 
even in developing countries.  Poor adherence, not only impedes medical progress, it 
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leads to increased morbidities, decreased mortality, and an increase in health care 
expenses.  Adherence involves a complex interplay between the patient, the provider, and 
the entire healthcare system, and nonadherence is affected by several factors, including 
social, economic, the health care team (i.e., services available, quality of 
communication), and the knowledge, beliefs, and attitudes of the patient (World Health 
Organization, 2003).     
The issue of medical adherence has been studied for some time.  According to 
Brannon and Feist (2004), adherence has been measured in 6 general ways:  (a) gathering 
information from the physician, (b) self-report of the patient, (c) collecting information 
from others, (d) counting medications, (e) examining biochemical substances, or (f) a 
combination of the various measures.  Kondryn, Edmondson, Hill, and Eden (2011) 
categorized the various ways to measure adherence into two groups, direct and indirect 
measure categories. They included those cited above, in addition to observations and the 
assessment of therapeutic outcomes. 
Direct measures, according to Kondryn et al. (2011), include such approaches as 
observations and blood and urine screenings.  Although observations by health care 
professionals can directly measure adherence, these measures can be time consuming and 
they do not necessarily typically take into consideration the health status of the 
individuals being assessed.  Whereas blood and urine screenings provide objective 
confirmation that a drug has been taken, blood sampling is an invasive procedure, can be 
costly, and you must also consider such factors as absorption and metabolic rates.  Urine 
screenings, on the other hand, are less invasive, but still can be costly and you must also 
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consider pharmocokinetics of the medication (e.g., the half-life or metabolic absorption 
rates of the drug).  Although, biochemistry measures do have disadvantages, they can 
provide a more objective way of measuring adherence.  Unfortunately, not all treatments 
can be measured in this manner.        
Kondryn et al. (2011) categorized patient self-reports, health professional ratings, 
prescription monitoring, pill counting, medication monitoring systems, and assessment of 
therapeutic outcomes, as indirect measures of adherence.  Whereas patient self-reports 
and health professional ratings are easy to administer and implement, they are also not 
without flaws.  The primary issue is accuracy or validity in reporting due to their 
subjectivity.  On the other hand, individuals completing self-reports, may fail to report 
inaccuracies for various reasons (e.g., the patient does not want to appear non-compliant, 
forgetting).  
Another indirect measure, prescription monitoring, involves measuring 
prescriptions filled.  Although this can be very useful with large samples, it does not 
measure the amount of medication taken.  Pill counting also is easy to implement, but 
does not actually confirm that the medication has been taken by the participant.  For 
example, when counting medication, the patient may remove part of the medication to 
appear adherent (Kondryn et al., 2011). 
Medication management systems, which continually assess timing and frequency 
of medication compliance, are based on the assumption that the medication has been 
consumed.  This method can also be costly, and there is always the potential for 
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mechanical failure.  The literature shows that, although all approaches have their 
disadvantages, the least valid approach is physician report (Brannon & Feist, 2004).  
Young Adults with Cancer and Treatment Adherence  
Although cancer is the leading natural cause of death for teenagers/young adults, 
according to Kondryn et al. (2009), there has been little research conducted in the area of 
nonadherence in this population.  According to the authors, this may be due to the lack of 
valid measures to assess adherence in this age group.  Whereas there are few articles 
related to treatment adherence in young adulthood, there are several studies which focus 
on treatment adherence in adolescent cancer patients.  Most of these studies have been 
conducted in the United Kingdom and other countries outside of the United States.   
Additionally, most of these studies only investigate patients up to the age of 18, and two 
studies explore participants up to age of 24 (Kondryn et al., 2011), but did not include 
young adults between the ages of 25-40 years.  Following are some of these studies.   
Cohen (1986) conducted a retrospective chart review of 74 adolescent cancer 
patients between the ages of 13-19 years and found that 23% of the participants refused 
to complete all or part of their treatment.  Festa, Tamaroff, Chasalow, and Lanzkowsky 
(1992) conducted two studies which assessed prednisone and penicillin compliance, as 
measured by blood and urine samples, respectively, and found nonadherence rates of 
52% and 48% for adolescents, of a mean age of 15.6 and 19.1 years.  Smith, Rosen, 
Trueworthy, and Lowman (1979) also found noncompliance rates of 63% with 
prednisone urine screenings, while Kennard et al. (2004) reported a nonadherence rate of 
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27% with serum assay analysis of an anti-infection drug prescribed to adolescent cancer 
patients, 13-17 years of age.  
Dolgin, Katz, Doctors, and Siegel (1986), conducted two studies with 12-18 year 
old patients.  Utilizing physician assessment to measure adherence rates, 46% and 11% of 
the patients, respectively, were rated by the physician to be “poor” or “very poor” 
compliers in the studies.  Tebbi et al. (1986), measured adherence in 22 patients, between 
the ages of 10-23 years, by utilizing patient, and parent self-reports on self-administered 
chemotherapy.  Compliance rates were measured at three points in time post diagnosis 
(i.e., 2 weeks, 20 weeks, and 50 weeks).  The highest nonadherence rate in this study 
occurred at the 50 week post-diagnosis mark and was 47%. 
Kondryn et al. (2009) investigated adherence in 33 adolescent/young adult cancer 
patients, ages 16-24 years of age, with solid tumors.  In this study, adherence was 
measured with a 19 item questionnaire developed by the authors.  Results of this study 
indicated that there were no differences in adherence rates in regards to age, gender, age 
at time of diagnosis, diagnosis, or time since diagnosis.  However, patients did not adhere 
to approximately 38% of low-risk treatment components (e.g., taking the wrong dosage 
of medications) and up to 25% of high-risk treatment behaviors (e.g., seeking out help 
when developing a fever). 
Mitchell et al. (2004) conducted a retrospective physician-rating and clinical note 
review of 665 patients from a cancer registry database.  The participants were between 
the ages of 10-24 years of age.  In this study, only 1% (i.e., 17) of the individuals was 
noncompliant in their treatment.  Additionally, Jamison, Lewis, and Burch (1986a) also 
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studied 12-18 year old patients using nursing ratings.  In this study, 100% of the 27 
outpatient participants were labeled as “moderately cooperative” with their treatment.  
Concerns regarding these studies include small sample sizes in all of the studies, with the 
exception of Mitchell et al. (2004).  Additionally, the adherence rates range from 37% 
(Smith et al., 1979) to 100% (Jamison et al., 1986a).  
Other Adherence Studies for Adolescents/Young Adults 
Wiener, Riekert, Ryder, and Wood (2004) compared and contrasted three 
medication adherence measuring methods in 35 adolescents/young adults, between the 
ages of 11-21 years, with HIV.  The adherence rates in this study, ranged between 31% 
and 54% for the three adherence measures: (a) clinical nurse ratings, (b) retrospective 
self-report interview, and (c) a 24-hour phone diary.  Friedman, Navaratnam, and 
McLaughlin (2010) found that the simpler the dosing regimen, the greater the adherence 
for asthma patients, ages 12-25 years of age.  In another study with asthma patients, ages 
12-20 years, Wamboldt, Bender, and Rankin (2011) found that beliefs, emotions, and 
knowledge effect adherence rates.  In this study, the authors found that poor adherence 
was related to misinformation about medication, lifestyle factors, and inaccurate 
assumptions about one’s disease.     
Older Adults and Cancer Treatment Adherence 
Several studies have investigated adherence in the older cancer population, but 
only one study was found which had compared adherence in younger adults to older 
adults.  This study compared three groups of adult cancer patients (i.e., 50 years of age 
and younger, 50-65 years of age, and 65 years and older) in regards to their adherence to 
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long-term adjuvant hormonal therapy for 8,796 early stage breast cancer patients.  Only 
49% of the participants were fully adherent in this study and those patients younger than 
40 years of age and older than 75 years of age, were the least adherent.  It is important to 
note that the therapy is prescribed for 5 years or longer (Hershman et al., 2010).  
Cooper, Schultz, Simkins, and Lafata (2007) reviewed the medical claims and 
electronic medical records of 429 cancer patients receiving treatment, with the intent to 
cure the patient.  Patients were studied throughout the initial 18-month follow-up period 
and categorized as either adhering to follow-up:  (a) less than recommended, (b) 
recommended, or (c) greater than recommended, per the oncology practice guidelines.  
This study excluded patients younger than age 30, and the mean age of the patients was 
62.4 +/- 11 years.  The authors were attempting to determine the feasibility of using 
administrative record reviews to measure guideline adherence.  Results of this study 
indicated that adherence rates were highest for laboratory tests, and lowest for physical 
examinations.  Additionally, patient reports were consistent with the medical record data, 
and there did not appear to be differences, according to insurance type.  The authors 
reported that there is little known about follow-up in cancer patients, and tumor registries 
do not do a good job of monitoring follow-up, or surveillance care, after treatment.       
Other studies have also looked at older cancer patients.  Weggelaar et al. (2011) 
compared three older breast cancer patient age groups (60-69 years, 70-79 years, 80+ 
years) in relationship to their adherence to surgery, radiation therapy, chemotherapy, 
systemic, and endocrine therapy, as recommended by the established guidelines in the 
Netherlands.  Results of this study showed significantly lower treatment adherence rates 
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for surgery, radiation, and systemic therapy for the 80+ year’s age range, as compared to 
the two other groups, ages 60-69 years, and 70-79 years of age.  However, the oldest 
group of participants was more likely to follow endocrine therapy recommendations as 
compared to the two younger groups. 
In another study, Stensvold et al. (2011) found that over 88% and 80% of older 
male prostate cancer patients during two time periods, adhered to the recommended 
surgical and radiotherapy guidelines.  Xu et al. (2012) found that adherence reduced over 
the course of a 5-year follow-up.  In this study, 116 males diagnosed with receptor 
positive breast cancer, received a 5 year prescription for Tamoxifen.  Adherence rates 
steadily dropped from 64% at the 1 year mark, 28.7% at the 3 year mark, to 17.7% at the 
5 year mark.   
Other Adherence Studies 
Stilley, Bender, Dunbar-Jacob, Sereika, and Ryan (2010), conducted three studies 
which explored cognitive function in relationship to medication nonadherence, and there 
was evidence of nonadherence in all three studies.  The first was a longitudinal study and 
included patients 24-60 years of age and examined their adherence to a hyperlipidimia 
medication.  Poor working memory appeared to account for poor medication adherence 
in this study.  The second study included 350 adults diagnosed with Type 2 diabetes.  The 
patients were, on average 63.7 years, and poor attention/psychomotor speed appeared to 
be a predictor of poor medication adherence in this study.   In the third study, 34 breast 
cancer patients, with an average age of 59.76 years, were investigated in order to 
determine if a hormonal agent impacted cognitive function, and if poor cognitive function 
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impacted medication adherence rates.  Verbal learning, attention, and memory all 
predicted medication adherence. 
Whereas Xu et al. (2012) found that social support appeared to be related to poor 
adherence rates, Foulon, Schoffski, and Wolter (2011) found that the patients’ 
perceptions of the importance of the treatment and how satisfied they were with their 
medical care were the most important factors in adherence.  Kirk and Hudis (2008) also 
explored the barriers of compliance with oral anticancer agents.  Results of this study 
indicated that education on how the medication can improve clinical outcomes, and how 
well managed the side effects were the most important factors in treatment adherence. 
Hillen, Hanneke, de Haes, and Smets (2011) reviewed 45 articles between the 
years of 1988 and 2008 and found that trust in the physician helped improve 
communication, reduce fears, and increase treatment adherence.  The authors also noted 
that trust was enhanced by the physicians’ competency level, honesty, and the degree to 
which they were patient-centered.  Kaiser et al. (2010) found that Black women were less 
trusting of their primary physician and cancer treatment team than Caucasian and 
Hispanic women.  
Garcia-Gonzalez et al. (2008), on the other hand, explored self-reported treatment 
adherence with rheumatoid arthritis and lupus patients.  In this study, 40% of patients 
stopped medication due to the side effects and 20% stopped due to their belief that the 
medication was not effective.  One third of the participants reported never forgetting to 
take their medication.  In this study, 23% of ethnic minorities did not adhere, and 
individuals with lower education and more side effects were less likely to adhere. 
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Although variables, such as gender, ethnicity, education, and income, have been 
explored in relationship to adherence, individuals are very inconsistent in their adherence 
behaviors (e.g., someone may adhere to taking medication but not to an exercise 
regimen), so these variables may or may not be good predictors of adherence overall 
(Dunbar-Jacob & Schlenk, 2001).  Following are some studies that have explored 
psychological and sociological variables related to adherence.  
Psychological Variables Explored in Relationship to Treatment Adherence 
Psychological variables such as autonomy, identity, and risk taking behavior, as 
they relate to age, may also play a role in nonadherence (Kondryn et al., 2009).  Blotcky, 
Cohen, Conatser, and Klopovich (1985) found that noncompliant adolescents reported 
lower levels of distress and state anxiety, but were higher on trait anxiety, religiosity, and 
external locus of control.  Additionally, adolescents who reported higher levels of 
depression and lower levels of self-esteem were more likely to be noncompliant (Kennard 
et al., 2004). 
A positive belief system regarding treatment side effects also can impact 
treatment adherence.  That is, individuals with more negative belief systems are less 
likely to adhere to treatment recommendations (Fink, Gurwitz, Rakowski, Guadanoli, & 
Silliman, 2004).  Additionally, Saratsiotou et al. (2010) found that patients’ belief system 
about the effectiveness of treatment also impacted adherence.  In this study, only 16.7% 
of patients who adhered to treatment reported that they believed it to be ineffective, 
whereas 62.5% of those who did not adhere reported that they believed the treatment to 
be ineffective.  
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Older patients are also less likely to adhere to treatment when depressed, possibly 
due to their decreased ability to tolerate treatment side effects (Demissie, Silliman, & 
Lash, 2001).  DiMatteo, Haskard, and Williams (2007) reported that nonadherence 
increases times three if depression exists.  Embarrassment is an emotion that also has 
been found to decrease the likelihood of receiving screenings for cancer, and may also be 
related to cancer treatment adherence (Magai et al., 2007).       
Psychological factors, such as depression, anxiety, and one’s belief system have 
been shown to be related to treatment adherence.  Additionally, sociological factors have 
been explored in relationship to adherence.   
Sociological Variables Explored in Relationship to Treatment Adherence 
Socioeconomic status is one sociological variable explored in relationship to 
treatment adherence.  According to Kissane (2009), poor screening, delayed treatment, 
and poor treatment adherence are all factors which may be impacted by lower 
socioeconomic status.  Whereas Jamison, Lewis, and Burrish (1986b) found only a 
moderate relationship between low socioeconomic status and treatment adherence, in a 
review of the literature, Kissane (2009) reported that low socioeconomic status and 
depression, are two of the most important psychosocial factors, which are directly tied to 
the behavioral pathway of treatment nonadherence.  
The family social system may also impact treatment adherence rates.  For 
example, parental involvement, especially the mother, has been shown to be related to 
treatment compliance to self-administered chemotherapy for teenage/young adult cancer 
patients (Malbasa, Kodish, & Santactoce, 2007).  Kennard et al. (2004) also found that 
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the greater the degree of incongruence, in the perception of the family environment 
between the parents and the child patients (ages 13-17 years), the increased likelihood of 
treatment noncompliance. This suggests that family conflict may also impact adherence.  
Additionally, in this study, those classified as noncompliant had lower survival rates 6 
years after the study.  DiMatteo (2004) also reported that social support and a cohesive 
family environment increases treatment adherence.     
Treatment and Disease Related Variables Associated with Adherence 
There are also treatments and disease related variables which have been found to 
be associated with treatment adherence.  Zebrack, Hamilton, and Wilder-Smith (2009) 
identified several factors related to a cancer diagnosis, which may impact treatment 
adherence for young adults.  They include disruptions in their daily living (i.e., work, 
school, career, and family), changes in their physical appearance, and subsequent body 
image issues, decreased energy, pain, nausea, altered social relationships, changes in their 
view of themselves, the future, and the world, and concerns about having to face their 
own mortality.   
According to Vermeire, Hearnshaw, Van Royen, and Denekens (2001), the more 
complex and the longer duration of the treatment regimen, and the more severe the side-
effects, the increased likelihood of noncompliance in teen/young adult cancer patients.  
On the other hand, treatment at a pediatric oncology facility, as opposed to an adult 
facility, increases the likelihood of treatment compliance for this population, likely due to 
the additional psychosocial services available and training of the healthcare team in 
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dealing with adolescent and young adults (Bleyer, 2007; McTieran, 2003), in addition to 
the higher participation in clinical trials in pediatric centers (Bleyer et al., 1997).  
Oral chemotherapy regimens also are related to poor treatment adherence.  In one 
study, 42 breast and colon patients and 10 medical professionals were interviewed 
regarding patient adherence rates.  Results of this study showed poor adherence to the 
dose schedule and the inability to recognize the signs of toxicity, as opposed to deliberate 
nonadherence, suggesting poor understanding by the patient, or poor education by the 
treatment professionals. With the increased usage of self-administered oral chemotherapy 
drugs, this is an area which will require further exploration (Denois et al., 2011).  
Saratsiotou et al. (2010) also found that length of time since diagnosis was the 
most important factor related to intentional treatment adherence.  In this study, 33% of 
patients who were newly diagnosed (i.e., less than 6 months) were not adherent to oral 
chemotherapy, as compared to 16.7% and 8.3% of patients diagnosed 6-24 months, and 
2-5 years, respectively.  The participants in this study ranged in age from 30-91 years.  
Although the study did not explore survival, one could speculate that those who were 2-5 
years since diagnosis, survived due to better adherence throughout treatment. 
Strategies for Increasing Adherence 
Due to the seriousness of the issue of treatment adherence with any cancer 
population, the lower treatment adherence rates of the young adult population, in addition 
to their lack of increase in survival rates, ways to improve adherence is an extremely 
important topic to consider.  The National Cancer Institute (2004) state that the biggest 
issue in adolescent/young adult oncology is the failure to recognize and address the 
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unique psychosocial needs of this population.  Furthermore, the Institute of Medicine 
(2003) state that whereas state-of-the-art biomedical treatment is available, there is a lack 
of psychosocial support, and the latter contributes to treatment nonadherence.     
Rabin, Simpson, Morrow, and Pinto (2010) interviewed 20 young adult cancer 
patients, between the ages of 18-39 years.  Participants were questioned regarding the 
behavioral and psychosocial oncology program needs and the barriers to program 
utilization.  The participants reported that they were interested in information related to 
exercise and physical activity, relaxation, receiving emotional support, nutrition, and 
weight loss.  They also reported that being able to make choices, having flexible and 
convenient treatment schedules, and being able to connect with others in their age range, 
was very important.  The barriers they identified included time constraints, lack of 
knowledge regarding programs, health related and treatment side-effect issues (e.g., 
fatigue and nausea), and low motivation. 
Zebrack, Hamilton, and Wilder-Smith (2009), recognize young adults with cancer 
as an underserved population, and advocate for treatment programs which help young 
adults maintain or develop independence, help them seek out information regarding their 
disease and treatment, manage their stress, cope with disease and treatment related side 
effects, seek out support, and maintain a positive attitude.  Other psychosocial needs of 
this population, according to Zebrack et al. (2009), are access to and an understanding of 
health care coverage, a multidisciplinarian approach to cancer care, access to clinical 
trials, and psychosocial counseling.  According to Sheard and Maguire (1999), group 
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therapy may be more effective than individual therapy, in reducing depression and 
anxiety in cancer patients, which one might speculate could improve adherence.     
The NCCN (2012) offered suggestions on how to increase adherence which 
includes education about treatment side effects at the onset of treatment, but also when 
treatment changes.  Education should also include a list of medications, dosage, purposes, 
and adverse side effects.  Additionally, the dosing schedule should be simplified, and the 
adolescent/young adult patients’ lifestyle should be taken into consideration when 
determining the timing, frequency, or mode of administration of medication.  Other 
recommendations include flexibility in scheduling appointments, education on healthy 
sexuality, recommending a healthy diet and exercise, and providing referrals when there 
are concerns about substance abuse.  Additionally, counseling and education on fertility 
preservation should be done at the onset of treatment, and concerns about faith should be 
addressed appropriately.  Providing links and education to patients on Medicaid, social 
security, and/or disability, in addition to food stamps may be necessary.  It may also be 
necessary to help identify respite care for patients with children, and provide information 
on survivorship and follow-up.   
Vourlekes and Ells (2007) reported that a social work, case management approach 
to helping promote adherence at all levels of medical care (e.g., prevention, treatment, 
follow-up) for a wide range of medical conditions is being developed. They advocate for 
a psychosocial case management “best practices” approach to improve treatment 
adherence, which includes an understanding to the barriers to treatment adherence, and 
provides a conceptual and theoretical framework to help with this.  Secondly, they 
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recommend a link between this framework with specific activities which promote 
adherence, and thirdly, the approach should be utilitarian and effective.  The authors 
further described a case management approach which includes five essential components.  
They reported that the approach must be integrated into the medical treatment, be 
multicultural, be individualized, the interventions must involve multiple systems, and 
there must be quality improvement studies to assess the effectiveness of the interventions.  
The authors recommended a case manager be assigned to the patient, and that the case 
manager be an active participant in the treatment team.  The case manager must have 
access to the patient’s chart and be readily available to the patient and healthcare team.  
Case managers should also be well versed in the understanding of different cultures, be 
multilingual if possible, and respect patients health care decisions which are influenced 
by their cultural beliefs and practices.  Case management interventions must also be 
individualized and patient-centered.  Each patient should be thoroughly assessed for their 
personal barriers to adherence, and interventions should be designed to reduce these 
barriers.  The adherence interventions should address multiple systems (i.e., the patient, 
the family, the heath care providers, the clinic, etc.).  Interventions should be designed to 
target barriers, such as transportation issues, childcare problems, and clinic hours, 
provide low cost or free medications, translation services, assistance with 
insurance/financial problems, and legal services. Finally, the case management program 
should be assessed periodically for quality improvement, and then steps taken to improve 
the quality of care, once a deficiency is identified.   
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Winkeljohn (2010) recognized nursing interventions to be a critical component in 
increasing adherence, particularly to oral chemotherapies, which are becoming 
increasingly more common in cancer treatment.  Winkeljohn advocated for nursing staff 
to be active participants in patient education regarding such issues as side effects (e.g., 
nausea and vomiting, diarrhea, hypertension, skin reactions, and suppression of the 
immune system), and side effect management, in addition to providing assistance in 
accessing medications. 
Kissane et al. (2012) also advocated for communication skills training for 
oncology professionals, in order to increase treatment adherence.  They believed that 
professionals should be trained to effectively educate patients on adverse reactions, how 
to share one’s diagnosis with family and friends, coping with survivorship, transitioning 
to palliative care, and prognosis.  Future communication challenges, according to the 
authors, include educating patients on issues related to genetic testing, the concept of 
“watchful waiting”, the cumulative effects of treatment, how to find accurate and useful 
internet information, and clinical trials.  
Summary and Conclusions 
In spite of improvements in survival for both pediatric and older adult cancer 
patients, survival rates have not increased for young adult cancer patients for two decades 
(American Cancer Society, 2012).   There have been several biological, psychological, 
and social factors which have been explored and theorized to help explain this lack of 
improvement in survival rates.  However, the majority of these studies have focused on 
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adolescent and young adult patients, between the ages of 15 and 23 years of age, or older 
adults.   
One biopsychosocial factor that may influence survival rates, treatment 
adherence, has received a great deal of attention in the literature.  Adherence rates in the 
adolescent literature has ranged from 33 to 60% (Kennard et al., 2004), and some studies 
have shown 100% compliance (Jamison et al., 1986a).  Although, treatment adherence in 
adolescence has been investigated, studies are lacking for the age range of 25-39 years, 
which is a group that also has not experienced an increase in survival.  There has also 
been one study that has been found thus far, which compares younger adults to older 
adults (Hershman et al., 2010).  However, this study is exploring adherence rates to oral 
chemotherapy which is prescribed for 5 years or longer.   
Additionally, although there is a sizable body of literature related to pediatric, 
young adult survivors of childhood cancer, and older oncology patients, there is less 
research on the adolescent/young adult population, and when studies are conducted on 
this population, the adolescents/young adults are often lumped in with the pediatric or 
older adult patients (Zebrack et al., 2009), such as in the Hershman et al. (2010) study.  
At this point, the gap in the literature appears to be related to the young adult population, 
more specifically the 25-39 year age range.  Therefore, due to this gap in the literature, it 
was worthy to explore the adherence rates of young adults, ages 18-39 years of age.  Poor 
adherence may also be an explanation for the differences in survival rates related to 
gender and race.  Due to these differences in gender and race in terms of survival 
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(National Cancer Institute, 2004), these variables were also of interest in relationship to 
adherence rates for this study. 
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Chapter 3: Research Method 
Introduction 
Young adult cancer patients have not shown an increase in survival rates over the 
past two decades, in spite of increases in survival for both pediatric and older oncology 
patients (American Cancer Society, 2012).  Although this lack of increase in survival 
rates may be related to many factors, one variable in consideration is treatment 
adherence.  The following study explored the relationship between the age of cancer 
patients and their adherence to radiation treatments and follow-up appointments.  More 
specifically, the study measures adherence rates to radiation treatments and follow-up 
appointments for young adult cancer patients, ages 18-39 years, as compared to cancer 
patients, ages 40 and older. 
The social change implications of the study are that it will potentially increase the 
knowledge base on the psychological factors which may explain the lack of increased 
longevity for younger adult cancer patients, as compared to pediatric and older oncology 
patients.  Furthermore, improved longevity in younger adult cancer patients would be 
expected to also have a positive impact on future generations.   
Purpose or Aim of the Study 
The purpose of the study was to explore radiation treatment and follow-up 
adherence rates for young adult oncology patients.  Failure to adhere to treatment and 
follow-up appointment recommendations may help explain the lack of improved 
longevity for the young adult group.  
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This chapter includes a description of the research questions and hypotheses, the 
research design and rationale for such design, followed by the history of the Cancer 
Registry, which is the data base, from which the data was collected.  Additionally, the 
methodology will be discussed, which includes a description of the setting, participants, 
the measurement of variables, and the procedure for data collection, followed by a 
description of the statistical and power analysis.  Additionally, ethical, validity, and 
reliability issues will be explored. 
Research Questions and Hypotheses 
This study explored the relationship between age of the cancer patient and 
adherence to cancer radiation treatment recommendations and physician recommended 
follow-up appointments.   
The following are the research questions and hypotheses for the study: 
1. Is there a significant difference in radiation treatment adherence for young 
adult patients as compared to older adult oncology patients?   
H01:  Young adult oncology patients do not adhere to radiation treatment less than 
older adult oncology patient. 
H11:  Young adult oncology patients do adhere to radiation treatment less than 
older adult oncology patients.   
2. Is there a difference between young adult cancer patients and older adult 




H02:  Young adult oncology patients do not adhere to follow-up appointments less 
than older adult oncology patients. 
H12:  Young adult oncology patients do adhere to follow-up appointments less 
than older adult oncology patients. 
3. Does gender impact adherence to radiation treatment? 
H03:  There is no association between gender and radiation treatment adherence.   
H13:  There is an association between gender and radiation treatment adherence. 
4. Does gender impact adherence to follow-up appointments?   
H04:  There is no association between gender and adherence to follow-up 
appointments.  
H14:  There is an association between gender and adherence to follow-up 
appointments. 
5. Does race impact adherence rates to radiation treatment appointments?   
H05:  There is no association between race and radiation treatment adherence.   
H15:  There is an association between race and radiation treatment adherence.   
6. Does race impact adherence to follow-up appointments? 
H06:  There is no association between race and adherence to follow-up 
appointments.   
H16:  There is an association between race and adherence to follow-up 
appointments. 
The independent variable was age group, and the dependent variables were 
adherence to radiation treatments and follow-up appointments (i.e., operationally defined 
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as the completion of at least 95% of the recommended treatment and follow-up 
appointments).  Gender and race were also explored in relationship to adherence.   
Research Design and Rationale 
The study was retrospective and quantitative in nature.  It included a secondary 
analysis of cancer registry data from which information about radiation treatment and 
follow-up adherence, cancer diagnosis, and demographic variables were extracted.  
Information not included in the registry data was gathered through paper and/or 
electronic patient chart review.  The data was gathered from the Cancer Registry of a 
community hospital in the Midwest.   Following is a description of the history and 
purpose of the Cancer Registry.  
Cancer Registry 
According to the Cancer Registry Bylaws, the first documented case with an 
etiology of cancer, occurred in the European Bills of Mortality in England in 1629, and 
the first collection of cancer data occurred in London in 1728.  From the mid 1800’s to 
mid 1900’s, various state and national cancer data collection registries developed in the 
United States and Europe.  Then, in the 1930’s, the Commission on Cancer (CoC) of the 
American College of Surgeons (ACoS), began collecting clinical information and 
approving cancer clinics.  By 1956, the Commission on Cancer began requiring CoC 
approved programs to have a cancer registry collecting cancer data.  As part of the 
Cancer Registry, cancer registrars are responsible for gathering data which provides a 
comprehensive summary of the patients’ history, diagnosis, treatment, and disease status 
for every cancer patient treated at their centers.  Demographic information collected by 
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the registrars include:  age of diagnosis, gender, race/ethnicity, birthplace and current 
residence.  Additionally the medical history (i.e., physical findings, screening 
information, occupation, history of previous cancer) and diagnostic findings (i.e., types, 
dates, and results of procedures) for the patient are included in the records.  Specific 
cancer information (i.e., primary site, cell type, extent of disease) and information related 
to therapies (i.e., surgery, radiation therapy, chemotherapy, hormone therapy, and 
immunotherapy) are also collected, in addition to follow-up information, such as 
reoccurrences and current patient status.  This data collection occurs in all approved 
programs in the United States and other countries.  The survival graph is the primary 
outcome objective of the cancer registry data collection, with the ultimate goal of 
improving treatment, thereby leading to a cure for cancer (Hutchinson, Menck, Burch, & 
Gottschalk, 2004).  
The National Cancer Data Base, which began in 1989, now contains cancer 
registry records from 1,500 accredited Commission on Cancer programs in the United 
States and Puerto Rico, with 29 million patient records (Hutchinson et al., 2004).  The 
program from which data will be extracted for this study was first accredited by the 
Commission on Cancer in 1977 (S. Dickinson, personal communication, March 5, 2015).  
The demographics for the database included in the study are:  (% male and female, % 
White, %Black, %Hispanic, %American Indian, % Other, % diagnosed between 18-39 






The setting of the data collection was a hospital-based community cancer center 
located in the Midwest.  The Cancer Registry department is located in the outpatient 
department of the cancer center, and employs two certified cancer registrars.   
Participants 
The target population for the study was oncology patients entered into the tumor 
registry of the aforementioned Midwestern Hospital.  With the assistance of a certified 
cancer registrar, the 46 available young adult cases were identified, and then 46 older 
adult cancer patients were matched on gender, race, and diagnosis.   Electronic and paper 
charts were then reviewed to gather data on treatment and follow-up attendance.  The 
target population consisted of two groups, one 18-39 years of age, and the other, ages 40 
and older.  Informed consent was not necessary, since the data was extracted from an 
already existing data base with prior consent given by the patients.  Power and sample 
size will be discussed later in the chapter. 
Procedure for Data Collection 
With the assistance of the Cancer Registrar, data from 46 patients diagnosed 
between the ages of 18 and 39 years, and data from 46 random patients diagnosed 
between the ages of 40 years and older was extracted from the cancer registrar’s data 
pool.  Once again, patients were matched on gender, ethnicity, and type of cancer, so that 
the groups were as similar as possible, with the exception of age range which is the 
variable being studied.  The METRIQ 2.82 (2015) cancer registry software was used for 
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extracting the data.  This software has the capabilities of extracting data by several 
variables, including age of diagnosis, year of diagnosis, gender, ethnicity, and year of 
first contact.  Data was extracted for patients diagnosed between January 2005 and 
August 2014.        
In order to determine radiation and treatment follow-up appointments, data 
collection then moved to chart review, either paper chart or electronic chart (which 
depended upon the admission date for the patient).  The electronic and paper charts have 
a listing of the date of treatment, activity or type of treatment, and status (which includes 
whether the treatment was completed or cancelled by the patient).   The information 
extracted from the electronic and paper charts was done manually by this researcher.    
Measurement of Variables 
Adherence to radiation treatments was measured utilizing a dichotomous variable 
of adherent vs. non-adherent to radiation treatments and follow-ups.  A cutoff of 95% of 
the recommended radiation treatments determined adherence, which is the recommended 
dosage for radiation treatment (International Commission on Radiation Units and 
Measurement, 2014; Radiation Therapy Oncology Group, 2011).  Additionally, follow-
up appointments were measured for the 2 years after completion of treatment, also with 
95% of the appointments attended as scheduled being the cut-off for adherence.  This 
information was measured, in that, follow-up appointments are recommended by the 
physician and recorded in the patient’s record, and then appointment status is 
documented in the records after completion or cancellation.   
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Appointments with other medical personnel were not included in the analysis, 
because of the difficulty in measuring these appointments.   In the case of missing data, 
every attempt was made to gather information from other areas of the patient record.  If 
the information could not be found, then the case was eliminated from the study.  
Additionally, patients who stopped treatment due to change of treatment centers were 
eliminated from the study.   
Operationalization of Variables 
Independent Variable:  Age range categorized into two groups (Young adults with 
cancer, ages 18-39 years of age, and Older adult cancer patients, age 40 years and older)   
Dependent Variable 1:  Radiation treatment adherence was dichotomized as either 
adherent vs. non-adherent with attending a minimum of 95% of radiation treatment 
appointments as scheduled, being considered adherent. 
Dependent Variable 2:  Follow-up appointment adherence was dichotomized as 
either adherent vs. non-adherent with 95% of appointments attended, within 2 weeks of 
the recommended appointment time being considered adherent. 
Gender:  Categorized as either Male or Female 
Race:  Categorized as Minority or non-Hispanic Whites  
Data Analysis 
IBM SPSS Statistics 21 (IBM Corp., 2012) and Vassarstats online calculator 
(2016; vassarstats.net/propcorr.html) were utilized for the data analysis.  McNemar’s test 
was utilized to examine the association between ages (i.e., young adults versus older 
adult oncology patients as the independent variable) in relationship to the two dependent 
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variables, adherence rates (dichotomized as adherent vs. non-adherent) to radiation 
treatment and follow-up appointments.  Pearson’s Chi-square analysis was used to 
examine the associations between gender, and race to the two dependent variables 
(radiation adherence and follow-up adherence). 
Power and Sample Size  
Sample size analysis for McNemar’s with a power of .80, using a one-tailed test 
with an alpha of .05 indicates that the study will need at least 18 participants 
(http://powerandsamplesize.com/Calculators/Compare-Paired-Proportions-McNemar-Z-
test-1-Sided). Eligible participants were patients who were diagnosed between January 
2005 and August 2014.  In order to compensate for missing data, over sampling was 
utilized and there will be 92 participants (i.e., 46 matched pairs) in the study.   
Ethical Issues 
Because the data were already collected, there were no concerns for influencing 
the data.  Additionally, the data were de-identified to protect the confidentiality of the 
patients in the event of publications and presentations.  However, one potential ethical 
issue was that this data collector works as an oncology counselor in the setting where the 
data was collected, and when accessing the medical records by this counselor, the data 
then became identified.  However, once again, the data cannot be influenced by the 
researcher.   
Threats to Validity and Reliability 
The measurement of radiation treatment attendance and follow-up treatment 
attendance was a good measure of adherence, giving the study good face validity.  
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However, because the data was only extracted from one hospital, the results cannot be 
generalized to other cancer registry data.  Additionally, datum could be missing on some 
of the cases, thus adding concerns about sample selection.  Furthermore, the measure may 
not have had good predictive validity (i.e., it does not necessarily predict adherence to 
chemotherapy or other forms of cancer treatment).  This also directly ties with divergent 
validity, in that, the adherence rates to radiation treatment and follow-up appointments, 
do not necessarily correlate with other treatment modalities (e.g., chemotherapy, 
surgery).  Additionally, radiation treatment adherence and follow-up treatment adherence 
may also not be related.  For instance, some patients adhered to radiation treatment in this 
study, but did not adhere to follow-up appointments, thus making the modality of 
treatment, an extraneous variable. 
Additional concerns about threats to external validity included that the study 
cannot be generalized to diseases and treatments, other than cancer.  Additionally, the 
study cannot be generalized to other time periods, past or present, and only applies to the 
time period for which the data was extracted.   Additionally, since this is the first study of 
its kind, comparing young adult and older cancer patients, on radiation and treatment 
follow-up adherence, it is unclear if subsequent studies will have similar outcomes, so 
replication is recommended in order to determine the reliability of the results. 
Summary 
This study was a quantitative analysis of Cancer Registry data.  It was 
hypothesized that there would be a difference in radiation treatment and follow-up 
adherence rates for young adult oncology patients, as compared to older oncology 
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patients.  Additionally, gender and race were explored to determine if these variables 
impact adherence rates.  The implications of the study were that a better understanding of 
treatment adherence rates, would lead to better treatment compliance, thus improving 
survival rates for young adult cancer patients. 
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Chapter 4: Results  
Introduction 
The purpose of the study was to compare young adult oncology patients’ 
adherence rates to radiation treatment and follow-up appointments, to older oncology 
patients’ adherence rates to radiation treatment and follow-up appointments.  Age was 
explored in relationship to adherence to radiation treatment and follow-up appointments 
using McNemar’s nonparametric test for matched pairs (i.e., two related samples), and 
Pearson’s chi-square analysis was used to examine the associations between gender and 
race with radiation and follow-up appointment adherence.  The following will include a 
description of the data collection procedure and the results of the study.   
Data Collection 
The data were collected in March 2015 from the cancer registry database of a 
Midwestern community hospital-based cancer center.  Data were gathered on all young 
adult cancer patients (ages 18-39 years of age) who had received radiation treatment at 
the aforementioned cancer center, with an initial cancer diagnosis between January 2005 
and August 2014.  Demographic data including gender and race, in addition to primary 
diagnosis and age of diagnosis, were extracted from the database with the assistance of 
the cancer registrar.  Fifty-nine young adult cases were identified, but 11 were not 
included due to them having a thyroid diagnosis, which is treated differently than the 
standard external beam radioactive therapy received for the other diagnoses.  
Additionally, one case was a duplicate case, which received treatment followed by 
palliative care radiation treatment at a later date, and another case was a duplicate with 
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two similar diagnoses, with only one course of treatment completed.  This left 46 young 
adult cases for analysis.    
For the older adult population, there were 1,502 cases identified, including 689 
females and 813 males.  The thyroid cases were also not considered from this population 
for the reason stated previously.  The older adult sample was identified by matching 
gender, race, and primary diagnostic site to the young adult sample.  When there were 
multiple matches, an online randomization tool called the Stat Trek Random Number 
Generator (http://stattrek.com/statistics/random-numb) was used to choose a match.  Six 
of the young adult cases did not have an identical match on all variables.  For four of 
those cases, they were matched on all variables with the exception of diagnosis.  In those 
instances, a case was identified with a similar diagnostic site (e.g., oropharynx was 
substituted for a nasal cavity).  In one of those four cases, an unknown primary site was 
substituted with a randomly chosen lung case.  Two cases could be matched on gender, 
and diagnosis, but not for race; hence, a patient with a different race was randomly 
chosen.  Additionally, four of the older adult cases did not have sufficient information to 
analyze the follow-up appointment adherence.  For example, one patient moved after 
treatment, another was referred to the medical oncologist for follow-up, and another was 
referred to hospice.  For these four cases, four substitute cases were randomly chosen 
matched on gender, race, and diagnosis.  Because one of these cases did not have a match 
on diagnosis, a similar site was chosen (e.g., lymphoma was replaced with a lung 
diagnosis).    
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Once the cases were identified, radiation treatment and follow-up data were 
extracted from the patients’ electronic and/or paper chart.  Radiation treatment 
appointments were measured as being completed on time if the patient completed the 
appointment as scheduled.  Absences were only considered excused if the patient’s 
radiation oncologist recommended a pause in treatment, or if the patient had a 
documented medical emergency or procedure that prevented him or her from attending 
his or her treatment appointment.  Follow-up appointment data were gathered for 2 years 
post the final treatment date.  Patients were considered adherent if they attended the 
follow-up appointment within 2 weeks of the recommended time period according to the 
patients’ follow-up summaries in their charts.  Patients were considered adherent on both 
variables if they attended 95% of their appointments as scheduled.   
Results 
Table 1 includes the demographic data for the young adult (N=46) and older adult 
(N=46) samples.  Both samples were predominantly female and White/non-Hispanic.  
The most common occurring diagnosis for both samples was breast cancer.  The average 
age of the older adults was 64.54 years, while the younger adult sample mean age was 




Demographic Characteristics for Young Adults (N=46) and Older Adults (N=46) 
Age M (SD) 33.17 (59.30)- 18-39 
years 
 64.54 (11.62)- 42-92 
years 
 N % N % 
Females 33 71.74 33 71.74 
Males 13 28.26 13 28.26 
Asian/Non-
Hispanic 
2 4.30 1 2.20 
Black/Non-
Hispanic 
2 4.30 2 4.30 
Filipino/Non-
Hispanic 
1 2.20 1 2.20 
Pakistani/Non-
Hispanic 
1 2.20 1 2.20 
Unknown/Unknown 1 2.20 __ __ 
White/Hispanic 7 15.20 7 15.20 
White/Non-
Hispanic 
31 67.40 33 71.70 
White/ Unknown 1 2.20 1 2.20 
Diagnosis: Base of 
Tongue 
1 2.20 1 2.20 
Diagnosis: Benign 
Brain 
1 2.20 1 2.20 
Diagnosis: Brain 2 4.30 2 4.30 
Diagnosis: Breast 20 43.50 20 43.50 
Diagnosis: Cervix 2 4.30 2 4.30 
Diagnosis: Kidney __ __ 1 2.20 
Diagnosis: Liver 1 2.20 __ __ 
Diagnosis: Lung __ __ 2 4.30 
Diagnosis: 
Lymphoma 






















1 2.20 __ __ 
Diagnosis: 
Oropharynx 
__ __ 1 2.20 
  
Diagnosis: Pancreas 1 2.20 1 2.20 




1 2.20 1 2.20 
Diagnosis: Rectum 1 2.20 1 2.20 
Diagnosis: Sarcoma 2 4.30 2 4.30 
Diagnosis: Skin 1 2.20 1 2.20 
Diagnosis: Small 
Intestine 
__ __ 1 2.20 
Diagnosis: Stomach 2 4.30 1 2.20 
Diagnosis: Testis 1 2.20 1 2.20 
Diagnosis: 
Unknown 
1 2.20 __ __ 
Diagnosis: Vagina 1 2.20 1 2.20 
 
Table 2 shows the frequencies and descriptive statistics for radiation treatment 
adherence and follow-up appointment adherence for both the young adult and older adult 
patients.  Whereas the majority of both young adults and older adult patients were 
adherent to radiation treatment, only a minority of both young adults and older adults 





Frequencies and Descriptive Statistics for Radiation Treatment and Follow-Up 
Appointment Adherence 
 Adherent N (%) Nonadherent N (%) Min% Max % 
Radiation Young 
Adults 
37 (80.43) 9 (19.57) 72.22/100.00 
Radiation Older 
Adults 








13 (28.26) 33 (71.74) .00/100.00 
Note. Min%/Max% = minimum % and maximum % of treatments and follow-up appointments completed 
by participants. 
 
Tables 3 and 4 show the adherence rates for young adult cancer patients (under 39 
years of age) and their matched controls on gender and race, for adherence to radiation 
treatment (Table 3) and adherence to follow-up appointments (Table 4). 
Table 3 
Adherence to Radiation Treatment Among 46 Cancer Patients Under 39 years and Their 
Matched Controls 
 Older Adherent Older Nonadherent Total 
Younger Adherent 34 3 37 
Younger 
Nonadherent 
7 2 9 
Total 41 5 46 





Adherence to Follow-Up Among 46 Cancer Patients Under 39 years and Their Matched 
Controls 
 Older Adherent Older Nonadherent Total 
Younger Adherent 2 3 5 
Younger 
Nonadherent 
11 30 41 
Total 13 33 46 
Note. Numbers in table are for pairs. 
 
Hypothesis 1 
Hypothesis 1 stated that young adult cancer patients (ages 18-39 years) would 
adhere less to radiation treatment than older adult cancer patients.  The independent 
variable was age (i.e., young adult oncology patients versus older adult oncology 
patients), and the dependent variable was adherence, versus nonadherence to radiation 
treatment.  According to the results of the McNemar’s test, there was no difference 
between young adult and older adult radiation treatment adherence.  See Table 5. 
Hypothesis 2 
Hypothesis 2 stated that young adult cancer patients (ages 18-39 years) adhere 
less to follow-up appointments than older adult cancer patients.  The independent 
variable was age (i.e., young adult oncology patients versus older adult oncology 
patients), and the dependent variable was adherence versus nonadherence to follow-up 
appointments.  According to the results of the McNemar’s test, there was a significant 
difference between young adults and older adults in adherence to follow-up appointments 
(p < .05, OR=3.67, 95% CI of 1.02, 13.14).  That is, the odds of adhering to follow-up 




McNemar’s Nonparametric Test for Age Predicting Radiation Treatment Adherence and 
Follow-up Appointments Adherence  
 p Odd Ratio 95% CI 
Radiation Treatment 
Adherence by Age 
.1719 2.33 [.60,9.03] 
Follow-Up 
Appointment 
Adherence by Age 
.0287 3.67 [1.02,13.14] 
Note:  p=exact binomial, 1-tailed 
 
Hypothesis 3 
Hypothesis 3 stated that there is an association between gender and radiation 
treatment.  The independent variable was gender, and the dependent variable was 
radiation treatment adherence.  Pearson’s chi-square analysis was used to analyze if 
gender was related to radiation treatment adherence.  According to the results of 
Pearson’s chi-square analysis, gender was not related to radiation treatment adherence.  
See Table 6.  
Hypothesis 4 
Hypothesis 4 stated that there is an association between gender and adherence to 
follow-up appointments.  The independent variable was gender, and the dependent 
variable was follow-up appointment adherence.  Pearson’s chi-square analysis was used 
to analyze if gender had an impact on follow-up appointment adherence.  According to 
the results of the chi-square analysis, males were more likely to adhere to follow-up 
appointments than females, with a chi-square value of 5.216 and p < .05 and OR =.298 




Hypothesis 5 stated that there is an association between race and adherence to 
radiation treatment.  Although it was proposed in Chapter 3 that African Americans 
would be compared to all other races, due to the small number of African Americans 
(n=4), White/non-Hispanics (n=64) were compared to all other races combined (n=28).  
The independent variable was race, and the dependent variable was radiation treatment 
adherence.  Pearson’s chi-square was used to analyze if race impacted radiation treatment 
adherence.  According to the results of the chi-square analysis, race was not related to 
radiation treatment adherence.  See Table 6. 
Hypothesis 6 
Hypothesis 6 stated that there is an association between race and adherence to 
follow-up appointments.   The independent variable was race (i.e., non-Hispanic Whites 
versus minorities), and the dependent variable was adherence to follow-up appointments.  
Pearson’s chi-square analysis was also used to analyze if race was related to follow-up 
appointment adherence.  According to the results of the chi-square analysis, race did not 





Associations Between Gender, Race, and Adherence to Radiation Treatment and Follow-
Up Appointments 
 Pearsons Chi 
Sq 


















.713 .398 .595 [.177,2.002] 
Summary 
The purpose of the study was to compare young adult oncology patients’ (ages 
18-39 years of age) adherence to radiation treatment and follow-up appointments, to 
older oncology patients’ (i.e., age 40 years and older) adherence rates.  Additionally, I 
explored race and gender and their association with radiation treatment and follow-up 
appointments.  Overall, I found that there was a significant difference between young 
adult oncology patients and older adult oncology patient in follow-up appointment 
adherence, with older adults’ adherence being 3.67 times higher than younger adults.  
Gender was related to the follow-up appointment adherence, but not radiation treatment 
adherence, with males more likely to adhere to follow-up than females.  However, due to 
the small number of males in the groups, these results should be interpreted more 
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cautiously than Hypotheses 2.  Chapter 5 will provide a summary of the key findings, 




Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of the study was to measure young adults’ radiation treatment 
adherence and follow-up appointment adherence to older adults’ adherence.  The 
independent variables were age (i.e., young adult oncology patients as compared to older 
adult oncology patients), gender (i.e., male versus female) and race (i.e., minorities 
versus White/non-Hispanic), and the dependent variables were radiation treatment 
adherence and follow-up appointment adherence.  McNemar’s nonparametric test was the 
means of analysis for the first two hypotheses, and Pearson’s chi-square analysis was 
used for Hypotheses 3 through 6.  Participants were matched on gender, race, and 
diagnosis.        
The central findings of the study were that young adult oncology patients adhere 
to follow-up appointments to a significantly lesser degree than older adult oncology 
patients, with 37 of the 46 young adults, and 41 of 46 older adults, adhering to radiation 
treatment, and only five of the 46 young adults adhering to follow-up appointments, as 
compared to 13 of the 46 older adults.  The range of adherence was 0 to 100% for both 
groups with the average being 61.08% adherence for young adults.  Because adherence to 
treatment and follow-up can impact long-term survival, there is a need to further explore 
the reasons for low adherence rates to radiation and follow-up appointments for young 
adults.   
The central finding of this study was consistent with previous studies that have 
found young adults to exhibit poor adherence to medical treatments for a variety of 
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illnesses, including HIV and asthma (Friedman et al., 2010; Wamboldt et al., 2011).  
Although there have been few studies on treatment adherence for young adult oncology 
patients, for those studies that did include young adults in the sample, they were 
combined with adolescents and did not include young adults between the ages of 25-40 
years.  Similar to the present study, for those studies that did include young adults, the 
adherence rates ranged from 53% to 75% (Kondryn et al., 2009; Tebbi et al., 1986).  
Additionally, researchers have not explored radiation treatment and follow-up 
appointment adherence, and only one study compared young adults to older adult 
oncology patients (Hershman et al., 2010). Instead, the researchers measured medication 
dosage compliance and chemotherapy attendance.   In the Hershman et al. (2010) study, 
patients younger than 40 years of age and older than 75 years of age were less adherent to 
a long-term adjuvant hormonal therapy, as compared to adults between the ages of 40 and 
75 years.  The results of the Hershman et al. study cannot be likened to this study due to 
the long-term treatments (5 years) of the previous study, as compared to the few months 
of radiation treatment and 2 years of follow-up explored in the current study.   
I also found that gender was related to follow-up appointment adherence, with a 
certain degree of certainty.  However, these results should be interpreted more cautiously 
due to the differences in sample size between males and females.  Furthermore, 
unexpectedly, it was females who adhered less than males.  Because the mortality rates 
are higher for males less than 30 years of age, and older than 45 years of age, it would be 
important to further study this topic of adherence, comparing larger samples of males to 
females to assess gender as a variable that impacts adherence.  Additionally, African 
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Americans have the lowest cancer survival rates for all age groups older than 15 years 
(National Cancer Institute, 2006).  Therefore, this is also an area that requires further 
exploration with a larger sample to compare ethnic groups.  Additionally, scholars who 
have studied adherence and have compared gender and ethnicity have shown inconsistent 
results (Dunbar-Jacob & Schlenk, 2001), which indicate further exploration of gender 
and ethnicity as moderating variables in cancer treatment and follow-up appointment 
adherence with larger samples.  Also of interest, although not a hypothesis in the study, 
are the overall low adherence rates to follow-up appointments for both groups as 
compared to radiation treatment adherence.   
Although there were no identified scholars who compared radiation treatment 
adherence to follow-up appointment adherence, one researcher found that adult oncology 
patients, 31 years of age and older (with a mean age of 62.4 years), were more likely to 
adhere to laboratory tests and were less likely to adhere to physical examinations (Cooper 
et al., 2007).  In another study, there were lower rates of adherence for patients 80 years 
of age and older for surgery, radiation, and chemotherapy (Weggelaar et al., 2011).  
Cooper et al. (2007) that found that older adults are less likely to adhere to physical 
examination appointments is consistent with the results of the low adherence rates for 
follow-up appointments, the latter which is similar to a physical examination.    
Assumptions 
This study was based on the assumption that the demographic data, radiation 
treatment adherence, and follow-up appointment attendance information were entered 
correctly in the patients’ electronic and paper chart files.  Given that humans are not 
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fallible, there is always the possibility that there may be errors in the data, and because I 
did not directly collect the initial data, there is no way of knowing this.  Additionally, the 
data are secondary in nature and were not gathered for the purpose of this study; 
therefore, it may not have been collected in a way that was best for this study.   
Delimitations 
In this study, I measured radiation treatment adherence and follow-up 
appointment adherence for young adult oncology patients as compared to older adult 
oncology patients.  I did not measure chemotherapy adherence due to the multiple 
variables (e.g., diverse treatment regimens, side effects, and other complications that may 
interfere with treatment).  Additionally, I did not measure medical oncologist (i.e., 
chemotherapy) follow-up appointment adherence, primarily due to some of the patients 
attending follow-up with their medical oncologist in his/her office and some being 
followed at the clinic of the hospital from which the data were collected.  Additionally, I 
did not control for stage of disease or compare diagnoses as contributing factors to the 
adherence. 
Limitations 
One limitation of the study was that some patients may have continued to follow-
up with their medical oncologist, as opposed to the radiation oncologist, in spite of the 
recommendations of the latter.  This was not analyzed in the study.  However, this is not 
to imply that a medical oncologist would be a substitute for the radiation oncologist.  
There are many important reasons for following up with both as prescribed.  Radiation 
treatment can have long lasting effects on the skin and other organs that are not side 
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effects of chemotherapy.  Therefore, it would be equally important to follow through with 
radiation and follow-up appointments, in addition to medical oncologist follow-ups. 
Another limitation of the study was the difficulty in measuring follow-up 
appointment adherence.  Follow-up appointment adherence was measured by reviewing 
physician documentation in order to determine when the next patient follow-up 
appointment was scheduled.  Although follow-ups were documented, this was not as 
clear cut as the quantitative analysis of patients’ radiation treatment adherence whereas 
radiation treatment appointments were scheduled consecutively and clearly marked as 
absent or present, and follow-up appointments were not consistent across diagnosis or 
time period.  
Another limitation of the study was the small number of males versus females 
(i.e., 26 males and 66 females) and the small number of minorities (i.e., 28 versus 64 non-
Hispanic Whites).  Therefore, although Pearson’s chi-square analysis was conducted, and 
there were significant findings for gender on follow-up adherence, I cannot definitively 
state that gender did have an impact due to the smaller number of males in the study.   
Another limitation was that, although every attempt was made to exclude patients 
who stopped their follow-up appointments due to death, there was a minute possibility 
that some patients included in the study may have discontinued for that reason, and this 
was not documented in the records.  Furthermore, I did not consider cohort effects, 
diagnosis, stage of disease, insurance status, or transportation as contributing factors to 
adherence rates, nor did I explore a direct relationship between adherence and survival 
rates.  Additionally, the study cannot be generalized to young adult patients with other 
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medical issues, adherence to chemotherapy, or to treatment regimens which may change 
due to advances in treatment or changes in the diagnosis.  Another limitation was that I 
did not examine causal relationships.    
Implications 
The implications of the findings of the study are that lower adherence rates to 
radiation treatment and follow-up appointments for the young adult oncology population 
could be one explanation for the lack of increased survival rates for this age group.  
Young adults are the only age group of oncology patients that have not seen an increase 
in longevity over the past 20 years (National Cancer Institute, 2004).  A better 
understanding of the reasons behind such low adherence to follow-up appointments for 
this age group could potentially increase adherence rates, thus leading to earlier diagnosis 
of reoccurrences and leading to earlier treatment, thus potentially saving money by 
avoiding more advanced and longer treatments, and most importantly, increasing 
longevity.  Additionally, there is a need for interventions to improve adherence rates for 
young adult oncology patients. 
Recommendations 
Further studies should be conducted with larger samples and with more equal 
groups in regards to gender and race so that the interactions could be analyzed with more 
certainty.  Additionally, it is recommended that the reasons for adherence to follow-up 
appointments be furthered explored because the rates were low for both age groups.   
Because I did not directly explore the relationship between adherence rates and longevity, 
another area to explore is whether or not adherence rates are directly tied to survival 
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rates.  Perhaps a better understanding of gender and race as variables impacting 
adherence, along with a better understanding of the reasons for lower adherence to 
treatment follow-up appointments, could increase survival rates, decrease medical costs, 
and reduce insurance costs to patients and families.  Also because young adults are more 
likely to have young children, the psychological, sociological, and economic benefits of 
increased survival rates for young adult oncology patients could lead to social change 
(e.g., children with two living parents are less likely to endure the pain and suffering of 
loss and remain psychological healthy and continue to be contributing members to 
society). 
Conclusion 
In this study, I found lower adherence rates for young adult oncology patients to 
follow-up appointments, as compared to older adult oncology patients. Additionally, 
gender did impact follow-up appointment adherence.  However, the latter results should 
be interpreted more cautiously due to the unequal sample sizes for males and females.  
There is a need for further exploration of the topic in order to determine if adherence 
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